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ABSTRACT 
 
Background 
Informed Consent (IC) has been proposed as the optimal method for ensuring the 
ethical entry of patients into clinical trials.  IC is a vital part of the research process 
and as such entails more than obtaining a signature on a form.  The IC must be 
given freely, without coercion, and must be based on a clear understanding of what 
participation involves. 
 
Aim 
The overall aim of this study was to attain an understanding of participants' 
knowledge regarding informed consent when participating in a research project. 
 
Methods 
The study was conducted at two public hospitals in a city in the Eastern Cape 
Province of South Africa.  The quantitative study used descriptive survey design.  A 
self administered questionnaire was used as a tool for data collection.   
 
Results 
The sample size consisted of 170 women with an average of 25.9 years.  The 
majority had completed secondary level education. More than half of the participants 
did not have knowledge of the purpose of the original study.  The majority of 
participants did not have knowledge of their responsibilities. Forty-two percent gave 
uninformative responses and 26% indicated they did not know their responsibilities.  
None of the participants understood the concept of randomization. The majority 
(85.9%) of participants indicated that information provided on the IC forms was 
sufficient for them to decide to participate.   
 
Conclusion 
Despite extensive efforts to ensure that participants understood their participation in 
the original studies, this study found poor recall of vital information for IC.  A signed 
informed consent does not guarantee that participants understand information given.   
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Recommendations 
The existing methods of communicating and obtaining of an informed consent seem 
to be insufficient for participants to make an informed decision. A new approach with 
more interactive features such as combination of audio-visual techniques might 
increase the possibilities of the understanding.   
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OPSOMMING 
 
Agtergrond 
Ingeligte toestemming (IT) is voorgestel as die optimale metode  om die etiese 
toelating van die pasiënte vir kliniese toetse te verseker.  IT is 'n belangrike deel van 
die navorsingsproses en as sodanig behels dit meer as die verkryging van 'n 
handtekening op 'n vorm.  Die IT moet vrylik gegee word, sonder dwang en moet 
gebaseer wees op 'n duidelike begrip van wat die deelname behels. 
 
Doel   
Die algemene doel van hierdie studie is om 'n begrip van die deelnemers se kennis 
met betrekking tot ingeligte toestemming te bepaal, wanneer hulle deelneem aan 'n 
navorsingsprojek. 
 
Metodes 
Die studie is uitgevoer by twee openbare hospitale in ’n stad in die Oos-Kaap in 
Suid-Afrika. Die navorsingsontwerp is beskrywend van aard en ’n kwantitatiewe 
benadering is toegepas. ‘n Self-geadministreerde vraelys is as 'n instrument gebruik 
om data in te samel. 
 
Resultate 
Die steekproefgrootte het bestaan uit 170 vroue met 'n gemiddelde ouderdom van 
25.9 jaar. Die meerderheid van die vroue het opleiding tot op sekondêre vlak. Meer 
as die helfte van die deelnemers het geen kennis van die doel van die oorspronklike 
studie gehad nie.  Die meerderheid van die deelnemers het ook nie kennis van hul 
verantwoordelikhede gehad nie. Twee-en-veertig persent het nie toepaslike 
antwoorde gegee nie en 26% het aangedui dat hulle nie weet wat hul 
verantwoordelikhede in die studie is nie. Nie een van die deelnemers het die konsep 
van verewekansiging verstaan nie.  Die meerderheid (85.9%) van die deelnemers 
het aangedui dat die inligting wat deur die IT verskaf word voldoende was om te 
besluit of hulle aan die studie wou deelneem. 
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Gevolgtrekking 
Ten spyte van uitgebreide pogings om te verseker dat  deelnemers hulle deelname 
verstaan het in die oorspronklike toetsing, het hierdie studie die swak herroeping van 
belangrike inligting aangaande IT bewys.  ‘n Ondertekende ingeligte toestemming 
gee geen waarborg dat die deelnemers die inligting waarvoor toestemming geteken 
is, verstaan nie.  
 
Aanbevelings 
Die bestaande metodes van die kommunikasie en verkryging van ingeligte 
toestemming blyk onvoldoende te wees om deelnemers ingeligte besluite te laat 
neem.  ‘n Nuwe benadering met meer interaktiewe eienskappe soos ’n kombinasie 
van oudio-visuele tegnieke mag die moontlikhede om te verstaan, meer duidelik 
maak. 
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CHAPTER 1 
INTRODUCTION TO STUDY 
 
1.1 Introduction 
Informed consent (IC) refers to an agreement between the researcher and the study 
participant (or his or her legally authorised spokesperson) to provide the participant with 
full knowledge of all the possible risks and benefits involved in a clinical trial.  This 
agreement contains information of relevant facts related to the purpose, setting and 
rationale of the trial.  A researcher may be held responsible for an injury caused by an 
undisclosed risk while the participant is in the study.   
 
IC can be defined as a process of information exchange that by its very nature requires 
a dialogue between a patient and provider (Schenker, Wang, Selig, Rita & Fernandez, 
2007:294).  However Neff (2008:1338) states that consent is much more than just the 
form, regardless of time spent developing and modifying it.  In reality consent is about a 
process that includes a non-coercive communication between subject and investigator.  
Additionally obtaining informed consent implies giving information to potential 
participants regarding the nature of the research procedure, scientific purpose and 
alternatives to study participation (South Africa Department of Health, 2006).   
 
According to Vanderpool (2009:258) a fully informed consent results from a process of 
communication between researchers and potential subjects; 
 
1. that conveys sufficient, relevant, and required information about the research in 
question, 
2. that is comprehended by the subjects, 
3. who voluntarily or freely choose to enroll in the research. 
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Chapter one provides the reader with a general overview of the research study, which 
entails the investigation of the understanding of IC from participants who participate in 
clinical trials.  
 
 
1.2  Aim of the study 
The overall aim of this study was to attain an understanding of participants' knowledge 
regarding informed consent when participating in a research project.   
  
 
1.3  Objectives 
The objective of the study was to assess how well participants understood why they 
agreed to participate in a research project in relation to the: 
 purpose of the study 
 treatment procedures 
 schedule and duration of the study 
 confidentiality 
 potential risks 
 side effects or benefits 
 participant’s rights to withdraw 
 contact information and role in the trial 
 costs or incentives 
 Reason/s for participation. 
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1.4  Significance of the study 
There is currently no study that assessed communication and miscommunication of 
informed consent in South Africa.  The findings of this study may identify gaps that exist 
during communication of IC in research studies.  Furthermore the results of this study 
may help future researchers to explore more interactive features that can be 
incorporated when obtaining informed consent.   
 
 
1.5  Rationale 
The researcher is of the view that the participants do not always understand the full 
content of an IC.  It is not always that participants understand and know what they are 
signing for when they enrol in research studies.  Furthermore the researcher believes 
that participants confuse research with treatment.  According to Lidz (2006:535) 
therapeutic misconception means individuals may confuse the goals of the research 
with those of treatment and may make decisions that do not rest on adequate 
understanding.   
 
The researcher also believes vulnerability of persons and populations also do affect the 
communication of IC.  Participant’s vulnerability and their motivations for participation 
should be considered, so as to get sense of confidence that when they consent to 
participate in studies, they are truly informed.  According to Mkandawire-Valhmu, Rice 
and Bathum (2009:1732), it is important for researchers to understand, through 
research, the needs of the most vulnerable in our communities while at the same time 
maintaining their human rights and dignity.  There is therefore a need for further 
investigation into the understanding of research among vulnerable populations.    
 
Stellenbosch University http://scholar.sun.ac.za
4 
 
It has been documented that obtaining consent from certain female populations is a 
further challenge as women in poorer countries often lack formal education and may not 
understand the uncertainty or the risk that exists within some of the clinical trials (Mills, 
Nixon, Singh, Doima, Nayyar, & Kapoor, 2006:308).   
 
 
1.6  Background literature  
IC has been proposed as the optimal method for ensuring the ethical entry of patients 
into clinical trials therefore investigators have to obtain IC before enrolling participants in 
clinical trials (Joffe, Cook, Cleary, Clark & Weeks; 2001:1772).  The current system of 
human-subject-research oversight and protections has developed over the last five 
decades and the principles of conducting human research were first developed as the 
Nuremberg code to try to stop Nazi war criminals (Rice, 2008:1325).   
 
The Nuremberg Code has generally been seen as arising from the Nuremberg Medical 
Trial and Informed consent has been an axiom of post–World War II clinical research 
and practice. (Weindling, 2001:37).  IC is the first principle of the 10 principles of 
Nuremburg code of 1947 (Lindegger & Richter, 2000:313).  These authors posit that the 
aim of the code was to regulate clinical trials so as to prevent abuse of human subjects 
as that was practiced by the Nazi physicists during World War II.  It is generally 
accepted that IC, as required in human research, incorporates four views; 
 disclosure of all relevant information about the research 
 comprehension by the prospective participant of this information to make an 
informed decision 
 freedom from all coercion of the prospective participant 
 explicit and formal consent by the participant, usually in written form (Lindegger & 
Richter, 2000:313).  
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Obtaining informed consent can lead to misconceptions by participants.  For instance 
participants may consent to be involved in clinical trials as they may then feel that they 
are eligible to free medical services offered during their participation in the trials.  This is 
particularly evident in populations of low income status (Rothmier, Lasley & Shapiro, 
2003:1040).  In these populations of low income status, the severity of disease or 
unstable emotional status may also contribute to the lack of proper understanding of 
what is expected of them.   
 
The principle of IC is that consent is freely given without coercion from researchers or 
local community.  Therefore all trial related information should be presented in the local 
language, and should address varying levels of education, both written and oral 
presentation (Mills Nixon, Singh, Dolma, Nayyar & Kapoor, 2006:309).   
 
According to the South African Good Clinical Practice guideline (GCP), the participants 
should be informed that the trial involves research.  In addition the purpose of the 
studies and interventions must be communicated.  Furthermore the participants should 
be informed of the possibility of random assignment to intervention or control group.  
The researchers should clarify that neither the participant nor the researcher would 
know whether he/she will be allocated to intervention or control group.  The participants 
will fall in either of the groups by chance, the possibility of invasive procedures, what the 
subject’s responsibilities are in the trial and aspects of the trial are experimental should 
be communicated (South Africa Department of Health, 2006).   
 
The Nuremberg code was developed in 1947 and at that time there were no laws, 
regulations, codes, or formal documents that stated ethical standards for human-
subjects research.  The trial proceedings resulted in the development of a document, 
named the Nuremberg Code.  This document articulated the basic requirements for 
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conducting research in a manner that respects the fundamental rights of human 
subjects (Rice, 2008:1326).   
According to Carlson, Boyd and Webb (2004:708), there are 10 principles that were laid 
down to which must be followed by physicians when carrying out experiments on 
human subject and are as follows; 
1. The voluntary consent of the human subject is absolutely essential.  This means 
that the person involved should have legal capacity to give consent.  The participants 
should be able to exercise free power of choice, without the intervention of any 
element of force, fraud, deceit or duress.  This latter element requires that before the 
acceptance of an affirmative decision by the experimental subject there should be 
made known to him the nature, duration, and purpose of the experiment.  It must. 
The participant must be informed of the method and means by which the study is to 
be conducted, all inconveniences, hazards to be expected; and the possible effects 
upon his/her health from participation in the experiment.  The duty and responsibility 
for ascertaining the quality of the consent rests upon each individual who initiates, 
directs or engages in the experiment.   
2. The experiment should be such as to yield fruitful results for the good of society, 
unprocurable by other methods or means of study, not random and unnecessary in 
nature. 
3. The experiment should be so designed and based on the results of animal 
experimentation and acknowledge of the natural history of the disease or other 
problem under study that the anticipated results will justify the performance of the 
experiment. 
4. The experiment should be so conducted as to avoid all unnecessary physical and 
mental suffering and injury. 
5. No experiment should be conducted where there is an a priori reason to believe 
that death or disabling injury will occur; except, perhaps, in those experiments where 
the experimental physicians also serve as subjects. 
6. The degree of risk to be taken should never exceed that determined by the 
humanitarian importance of the problem to be solved by the experiment. 
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7. Proper preparations should be made and adequate facilities provided to protect 
the experimental subject against even remote possibilities of injury, disability, or 
death. 
8. The experiment should be conducted only by scientifically qualified persons. The 
highest degree of skill and care should be required through all stages of the 
experiment of those who conduct or engage in the experiment. 
9. During the course of the experiment the human subject should be at liberty to 
bring the experiment to an end if he has reached the physical or mental state where 
continuation of the experiment seems to him to be impossible. 
10. During the course of the experiment the scientist in charge must be prepared to 
terminate the experiment at any stage, if he has probable cause to believe, in the 
exercise of the good faith, superior skill, and careful judgment required of him, that a 
continuation of the experiment is likely to result in injury, disability, or death to the 
experimental subject. 
 
 
1.7  Research question and statement  
How well do participants understand informed consent?  It is the researcher's view that 
research participants may not always understand the full content of an informed 
consent. 
 
 
1.8  Research methods 
The research design will be covered in depth in chapter three.  This study used a 
descriptive design to explore how well participants understood informed consent when 
participating in a study.  A questionnaire was formulated based on the IC template of 
the World Health Organization.  The questionnaire consisted of 33 questions.   
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1.9  Study population and sampling  
The study was carried out in a city in the Eastern Cape Province.  Participants were 
recruited from existing studies conducted at a research unit.   
There were three studies taking place at the time of this survey.  The primary objectives 
of study B was to determine the demographic, socioeconomic factors, infant feeding 
practices, immunisation, and micronutrient status on infant growth, diarrhoea and 
respiratory diseases in infants of age six weeks to nine months.  Study A was a 
randomized controlled trial comparing efficacy, safety and acceptance of the intra 
uterine contraceptive device and injectable depot progestogen in reducing pregnancy 
rate.  The primary objective of study C was to assess whether massaging the uterus for 
30 minutes may be as effective, or more effective as oxytocin injection to prevent post-
partum haemorrhage. 
 
Only those who were able to converse (read or write or speak) in either Xhosa or 
English were recruited.  Participants were selected using convenience sampling.  Newly 
recruited participants who agreed to participate in the research unit studies were 
approached to participate in the IC study.  Informed consent was obtained from the 
participants, 8 to 48 hours after being successfully enrolled and signing informed 
consent to any of the research unit studies.  It was estimated that 50 women would be 
enrolled onto trials every month.  The statiscian advised on the sample size of 170 
participants.  It was calculated using power of 80% and p-value of 0.05.   
 
 
1.10  Data Analysis 
Quantitative data was entered onto a Microsoft excel sheet and analysed.  Findings are 
presented in tables and texts, interpreted and discussed.  The statistic test used was 
Chi-square.  The common themes and written descriptions of findings were formulated 
from responses of open-ended questions.  The qualitative analysis of the open ended 
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questions was done on all 170 questionnaires although it was expected that saturation 
of new themes would be reached after the first 50 questionnaires.   
 
 
1.11  Inclusion criteria 
All the participants that were at the time of the study, participating in any of the research 
unit studies and consented to participate in the IC study were included.  The participants 
had to be able to converse (read or write or speak) in either English or Xhosa.  
 
 
1.12  Reliability and Validity 
The pilot study was done to test the questionnaire for reliability and validity.  According 
to Burns and Grove (2007:552), reliability refers to the consistency with which an 
instrument measures what it is supposed to measure, while validity is the extent to 
which an instrument measures what it is supposed to measure.  Reliability testing was 
done to measure the amount of random error in the instrument; the data collectors were 
taught about the study and the procedures of how the study should be carried out.   
 
Validity is a reflection of the relationship between a concept being measured and the 
measurement itself (Burns & Grove, 2005:378).  Internal validity/truth-value was insured 
by being satisfied that the participants accurately understood the questions and agreed 
with the way it was interpreted.  The researcher clarified the information given to her 
with the participant to ensure that it was correctly understood.   
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The questionnaire was given to five experts to confirm, face, content and criterion 
validity.  A pilot study was conducted to test the questionnaire for reliability and validity. 
 
 
1.13  Ethical consideration 
A signed informed consent was obtained from the participants.  The proposal and 
informed consent to conduct this study was approved by Human Research Ethics 
Committee of University of Stellenbosch.  The research staff consisted of individuals 
who had completed a course in Good Clinical Practice within the past two years, 
assuring that the research would be done according to the ICH GCP guidelines.  The 
study was one of the larger studies taking place in the research unit.  Permission to 
carry out the study was sought at the institution and granted.   
 
 
1.14  Dissemination of results 
The report of this study will be submitted to Stellenbosch University as a fulfillment for 
the master’s degree in nursing and an electronic copy made available on internet via the 
university’s SUNscholar portal.  Papers will be presented at local and international 
conferences and a manuscript submitted to a peer reviewed accredited journal for 
publication. 
 
 
1.15  Budget 
The researcher’s study fees as well as any project related financial needs were funded 
by Family.  Initially the funding for transport to research site, school fees and paper 
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needed for printing as well as payment of the statistician was funded by NUFU and 
PROMISE PEP.   
 
 
1.16   Definitions  
Bias 
Bias is an influence that produces a distortion in the study results (Polit & Beck, 
2006:42).  
 
Clinical trial 
A clinical trial is a study designed to assess the safety and effectiveness of a new 
clinical treatment which sometimes may involve a number of phases, of which one 
(phase 2) is a randomised clinical trial using an experimental design (Polit & Beck, 
2006:496).  
 
Communication 
Communication is the process of sending and receiving messages between human 
beings and it includes both content and instruction proportions and feedback loops and 
can be digital and analogic (Friedman, Bowden & Jones, 2003:649) 
 
Ethics 
Ethics are systems of moral values that is concerned with the degree to which research 
actions adhere to professional, legal, and social obligations to the study participants 
Stellenbosch University http://scholar.sun.ac.za
12 
 
(Polit & Beck, 2006:499). Additionally ethics are referred to as the discipline that deals 
with principles of moral values and moral conduct (LoBiondo-Wood & Haber, 2010:577). 
 
Exclusion 
Exclusion is a criteria that specify characteristics that a population does not have (Polit 
& Beck, 2006:499).  It is the process of selecting those who are not legible to take part 
in the study or can be referred to as process of excluding or being excluded in a study.   
 
Inclusion 
Inclusion a sampling criteria with characteristics that the subject or element must 
possess to be part of the target population (Burns & Groove, 2007:325).  It is the 
Process of selecting those who are legible to take part in the study or can be referred to 
as a process of being included in the study. 
 
Informed consent (IC) 
An informed consent is an ethical principle that requires a researcher to obtain the 
voluntary participation of subjects after informing them of potential benefits and risks 
(Lobiondo-Wood & Haber, 2010:597).  In addition, Burns and Groove (2009:704), 
defines IC as a prospective subject’s agreement to voluntary participate in a study, 
which is reached after the subject assimilates essential information about the study.   
 
Miscommunication 
Miscommunication in research ethics is communication failure between the staff 
designated with the responsibility of providing IC and the participant.  This can occur 
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when insufficient information is provided or participant misunderstanding information 
provided.   
 
Participant 
Participant is an individual who participates and provide information in a study (Polit & 
Beck 2006:511).  Furthermore this individual provides the researcher with information 
relevant to the study or consents to be observed during the course of the research  
 
Understanding 
Understanding is when the participant can comprehend information provided by the 
researcher.   
 
 
1.17   Summary 
The purpose of chapter one was to acquaint the reader with a short overview of what 
could be expected of this research project.  This study is conducted to evaluate the 
understanding of informed consent when participants consent to partake in a clinical 
trial or any research study. 
 
Chapter one outlined the introduction of the project.  The next chapter provides a layout 
of literature on important aspects of informed consent.  The third chapter is a description 
of the methodology of the study as well as the instrumentation.  In chapter four, the 
results of both the qualitative and quantitative data are presented.  Chapter five contains 
a discussion of the results and recommendations are given.   
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1  Introduction 
A review of literature on informed consent (IC) was done to gain a background and a 
more in-depth understanding of all issues that may impact research participant’s 
understanding of IC.  Literature was searched in medical journals, PubMed, the National 
Library and various other resources available.   
 
This chapter covers an overview of the historic background of the origin of informed 
consent.  It covers the theoretical framework of informed consent that guides this study.  
Language barriers and issues related to the understanding of IC as well as the 
misconceptions that exist between treatment and medical research are also discussed.  
The gaps in the literature of informed consent have also been identified.   
 
 
2.2  Theoretical frame work  
 
2.2.1  Theory 
Theory is a creative and rigorous structuring of ideas that project a tentative, 
determined, and systematic view of phenomena (George, 2002:5).  According to 
LoBiondo-Wood and Haber (2010:58), it is a set of interrelated concepts, definitions and 
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propositions that present a systematic view of phenomena for the purpose of explaining 
and making predictions about those phenomena.  It is further viewed to suggest a 
direction on how to view facts and events and theories cannot be equated with scientific 
laws, which predict the results of given experiments hundred percent of time (George, 
2002:5).  Pilot and Beck (2006:511) refer to it as an abstract generalisation that 
presents a systematic explanation about the relationships among phenomena.   
 
 
2.2.2  Framework 
A framework is an abstract, logical structure of meaning, such as a portion of a theory, 
which guides the development of a study.  It is tested in the study and enables the 
researcher to link the findings to the body of knowledge used in nursing (Burns & 
Groove, 2007:540).   
 
A conceptual framework or theoretical framework of a research report is a structure of 
concepts and theories pulled collectively as a map for the study (LoBiondo-Wood & 
Haber, 2010:57).  The rationale for the map of the study provides rationale for the 
development of research questions or hypotheses (LoBiondo-Wood & Haber, 2010:57). 
 
 
 
 
 
 
Stellenbosch University http://scholar.sun.ac.za
16 
 
INFORMED CONSENT 
 purpose of the study 
 treatment procedures 
 schedule and duration of 
the study 
 confidentiality 
 potential risks 
 side effects or  
 
 benefits 
 participant’s right to 
withdraw 
 contact information and role 
in the trial 
 costs or incentives 
 reason/s for participation 
 
 
 
 
 
 
 
 
 
COMMUNICATION 
 Language (cultural 
uses & 
terminology) 
 Level of education 
(understanding 
 Questions and 
answers 
 Age  
 Comprehension 
 
  MISCOMMUNICATION
 Expectations and 
promises 
 Vulnerability 
(coercion, 
influence) 
 Therapeutic 
misconceptions 
ENROLMENT 
 The 
participants 
will then be 
enrolled in the 
study.   
 
 
Figure 2.1 conceptual map for Informed Consent Study 
(Developed by researcher from experience G.P.Moloi) 
 
 
 
 
 
 
CLINICAL TRIALS
Randomisation 
Intervention 
Control  
Placebo  
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As illustrated in figure 2.1, IC is detailed with information of purpose of the study, 
treatment procedures, schedule and duration of the study, confidentiality, potential risks, 
side effects or benefits and participant’ right to withdraw.  Others include, contact 
information and role in the trial as well as costs or incentives available and reason for 
participation (Department of health, 2006).  The communication process takes place 
before enrolment in clinical trials.  Communication brings about issues of language 
differences, cultural uses and terminology.  Issues relating to the level of education and 
understanding of information are evident during communication.   
 
There is a possibility of miscommunication before enrolment in clinical trials.  
Researchers can make promises that result in participants having higher expectations.  
The promises may indirectly result in coercion of the participants to enrol in the studies 
or therapeutic misconception by the participants.  Vulnerability of the participants may 
influence the extent of miscommunication and confusion of research versus treatment.  
The communication of research aspects such as randomisation, control, intervention 
and placebo takes place in clinical trials before enrolment of participants.   
 
 
2.2.3   Egoism 
The researcher believes that before you can think of somebody else’s interest you 
should think of yourself.  Before someone puts oneself in any commitment he/she must 
judges if it will be of benefit or compromise his/her life.  Egoism focuses on self-interest.  
This ethical principle is used as justification when something is done to further an 
individual's own welfare.  Asking the following question can best sum up the principle:  
Does the action benefit me, as an individual, in any way?  According to Pera and Van 
Tonder (2005:29) for the egoist, the morally right thing to do is whatever promotes self-
interest. An IC is meant for an individual to read and understand or to comprehend 
information provided and decides if it benefits his/her or if necessary for oneself to 
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participate in particular research studies.  The signing should be done after judging if 
the consent will benefit or compromise his/her life.   
 
 
2.2.4  Theory of Reasoned Action 
According to Webber, Martin and Corrigan (2007:2438), the Theory of Reasoned Action 
(TRA) includes behaviours that people perform because they choose to do so.  The 
TRA eludes an individual’s intention to perform a given behaviour as the single best 
predictor of that person’s behaviour.  The TRA would predict that if someone believes 
that people who are important to them would support the signing of consent, then they 
would be more likely to do so (Weber et al, 2007:2438).   
 
 
2.2.5   Utilitarianism   
According to Pera and Van Tonder (2005:30) utilitarianism assumes that one can weigh 
and measure harms and benefits and produce greatest possible balance of good over 
evil for most people.  According to Nord (2006: 67) utilitarianism permits the causing of 
harm to an innocent victim when doing so would likely cause benefit to others greater 
than the harm to the victim. Common morality, by contrast, does not accept this precept.   
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2.2.6  Developed theoretical frame work for IC study 
The researcher acknowledges that all individuals need to have full control of their lives 
and freedom to decide what is right and wrong for them to accomplish full control of 
one-self.   
 
It has been documented by  Pera and van Tonder (2005:152) individuals have the right 
to conduct their lives as autonomous agents without external control, coercion or 
exploitation, especially when they are asked to participate in research.  This basically 
refers to self- determination by an individual of what is right and wrong for them.  It is 
therefore the researcher’s responsibility to respect the autonomy of vulnerable 
individuals.  An individual must refrain from actions which may cause harm but do good 
over evil.   
 
 
2.3  History of informed consent  
It is documented that before World War II, the evidence-based medicine era, clinical 
research was an informal part of medical practice.  According to Rice (2008:1326), in 
the last half century, the level of oversight on human subjects has exploded from almost 
none to what is now an exhaustive system of protections.  Participants of such studies 
were frequently unaware that the treatments suggested by their physician were in 
essence experimental.   
 
The United States of America is named as the country of origin of the informed consent.  
The initial aim was to make sure that the correct dignity of the patient’s independence 
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and choice of medical options were reserved at the time of decision making (Mallardi, 
2005:313).   
 
 
2.3.1   Tuskegee experiment 
Early in the 1930’s, about 400 black men with syphilis were recruited in a study in 
Tuskegee, Alabama in order to investigate the natural progression of untreated syphilis 
(Cohen, 2008:704).  The men were informed that they had "bad blood values" and that 
they would get free treatment if they decided to join the study.  At the time of the study 
there was no cure for syphilis, but in the 1940's, with the introduction of penicillin as a 
cure of syphilis, the study participants were still denied treatment (Sharma 2009:256).  
Many of the participants were illiterate, which made it difficult for them to understand 
what they were going through.  The Tuskegee study was an important reason for the 
development of the Belmont Report (Cohen, 2010:704).  Subjects were denied the 
opportunity of informed consent and were coerced to join the study.  If they were 
properly informed they would have made an educated decision. Another disadvantage 
was that they were vulnerable due to being desperate for treatment.  Participants were 
promised that being involved in the study they would get free treatment. 
 
 
2.3.2  Nazi experiments 
The Nazi experiments were carried out in Germany.  The Jewish prisoners were 
tortured and usually to death.  There were more racial experiments carried out at the 
time of the Nazi experiments.  Some 300 prisoners were immersed in ice-cold water, or 
strapped naked to a stretcher in the Polish winter, while rectal temperature, heart rate, 
level of consciousness and shivering was carefully monitored and charted (Bogod, 
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2004:1155).  Most participants were allowed to freeze to death; in some resuscitation 
was attempted by various methods, with active reheating in a warm bath proving the 
most effective (Bogod, 2004:1155).   
 
According to the Good Clinical Practice Guideline (Department of Health, 2006) it is a 
person’s right to refuse or participate in research and that shows respect for human 
dignity.  The main ideal goal for process of informed consent is to make sure that the 
research participants make informed decisions prior to participating and then implement 
them.   
 
 
2.3.3   Nuremberg code 
A trial was done in Nuremberg, on December 19, 1946, of Nazi doctors and a code was 
defined in which the judges, all Americans, clearly emphasized a view of medical 
research and technology.  Science should never transform or consider human beings as 
an instrument to be employed for scientific purposes (Mallardi, 2005:313).   
 
At the time when the Nuremberg code was developed in 1947, there were no laws, 
regulations, codes, or formal documents that stated ethical standards for human-
subjects research (Rice, 2008:1326).  The trial proceedings resulted in the development 
of this document called the Nuremberg Code that articulated the basic requirements for 
conducting research in a manner that respects the fundamental rights of human 
subjects (Rice, 2008:1326).   
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This code has generally been seen as arising from the Nuremberg medical trial and 
Informed consent has been a saying of post–World War II clinical research and practice 
(Weindling, 2001:37).  IC is the first of the 10 principles in the Nuremburg code of 1947 
(Lindegger & Richter, 2000:313).  These authors state that the aim of the code is to 
regulate clinical trials so as to prevent abuse of human subjects as practiced by the 
Nazi physicists during World War II.  It is generally accepted that IC, as required in 
human research, incorporates four views; 
 disclosure of all relevant information about the research 
 comprehension by the prospective participant of this information to make an 
informed decision 
 freedom from all coercion of the prospective participant 
 explicit and formal consent by the participant, usually in written form (Lindegger & 
Richter, 2000:313).   
 
The ten principles can be summarized in three basic principles.  These are; 
 the researchers’ responsibility towards the research subject shall always be 
greater than that towards the society, 
 the ethical aspects between therapeutic and non-therapeutical trials differ from 
each other, 
 the concept of giving informed consent is essential. 
The full list of the 10 codes is listed in Chapter One (page 5).   
 
It can be concluded that the Nuremberg Code arose from the concerns of allied medical 
war crimes investigators as they encountered the survivors of the human experiments 
and gathered the records of medical atrocities in concentration camps and clinics 
(Weindling, 2001:70). 
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2.3.4  1964-The declaration of Helsinki 
The Declaration of Helsinki (DoH) was first adopted in 1964 and it has risen to a 
position of prominence as a guiding statement of ethical principles for doctors involved 
in medical research (Carlson, Boyd & Webb 2004:696).  The DoH was developed by 
World Medical Association and is a further development of the ethical principles of the 
Nuremberg code (Striefel, 2001:41).   
 
 
2.3.5  1979-Belmont Report 
The Belmont Report is an approximately 5,500-word document that describes three 
fundamental principles that are now accepted as the minimum requirements for ethical 
human-subjects research (Rice, 2008:1328).  In April of 1979, Belmont Report was 
issued, which established the ethical principle for the treatment of research subjects in 
the United States.  The three ethical principles to guide the conduct of research 
involving human subjects that are; 
 respect for persons, 
 beneficence and 
 justice (Byerly, 2009:177). 
 
The above principles are generally accepted and are particularly relevant to the ethics 
of research involving human subjects. 
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Respect also called the autonomy principle, has also been addressed in the Nuremberg 
code and points out that informed consent should, if possible, be made prior to 
research. 
 
Justice states that individuals should be selected justly.  In other words vulnerable 
participants should not take part in studies unless there are strong motivations for these 
individuals to partake. 
 
Beneficence means that benefit profile must be analysed and that the benefits must 
clearly outweigh the risks in order to proceed with the research (Byerly, 2009:177).   
 
 
2.3.6  1974-The National Research Act  
According to Byerly (2009:176), the revelation of the Tuskegee Syphilis Study led to the 
National Research Act of 1974 in the United State of America.  The National Research 
Act led to the establishment of modern Institutional Review Board (IRB) system and 
ethical standards for human research subjects (Rice, 2008:1328).  The legislation 
created the National Commission for Protection of Human subjects of Biomedical and 
Behavioral research. 
 
 
2.3.7  The Institutional Review Board 
Byerly (2009:176), states that the Nuremberg Doctor’s Trial that occurred at the end of 
World War II is commonly cited as the experience that drew attention to the need for a 
formal system for the protection of individuals who participate in research studies.  The 
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United States of America (USA), National Research Act paved a way for the modern 
IRB system of regulating human-subjects (Rice, 2008:1328).  IRB review is integral to 
ensuring regulatory compliance and ethical conduct of research involving human 
subjects (Byerly, 2009:182).  Over the years, much has been done to secure protection 
for participants in clinical research.  No research on humans will be done without 
considering how best to protect the interests of the research subject.    
 
 
2.3.8  GCP guideline 
The GCP guideline is an integrated scientific quality standard for designing, recording 
and reporting trials involving participation of human subjects (South Africa Department 
of Health, 2006).  The GCP guidelines contain information on what informed consent 
should contain in order to give the potential participant the opportunity of making an 
educated informed decision.  The agreement also contains the procedures regarding 
the handling of the informed consent form between the researcher, institutions and 
participant.  The concepts are as explained below (South Africa Department of Health, 
2006).  
 
 
2.4  Principles of informed consent for trial participants 
According to GCP guidelines, in conduct of Clinical Trials with human participants, there 
should be an adequate information package available for use in the process of seeking 
IC for participants of the study.  It should include contact details for the Medical Control 
Council and the relevant research ethics committee.  It is further stipulated in the 
guidelines that both the IC discussion and the written IC form and any other written 
information to be provided to participants should include explanations of the following;  
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The participant must be aware prior to participation that the study is done to find out 
answers for the researcher and not treatment (South Africa Department of Health, 
2006).  According to Lidz (2006:535) individuals may confuse the goals of research with 
those of treatment and may make decisions that do not rest on adequate 
understanding.  This is referred to as therapeutic misconception.   
 
It is further stipulated in the GCP guidelines that, it is vital for participants to be aware of 
the purpose of the trial.  The information regarding trial treatment should be clearly 
explained and possibility of random assignment to each in cases of randomised trials.  
The participants must be aware of the procedures to follow responsibilities before 
joining.  Participation should be voluntary and participants should be informed that they 
have right to refuse and that will not affect their routine care.  The participant should be 
made aware of the expected duration of participation, benefits and risks.  The 
compensation and treatment available in the event of trial related injury and requirement 
to preserve confidentiality must be clarified.  The contact name, number of the Principal 
Investigator (PI) and directly responsible investigator and identity of a sponsor should 
be provided (South Africa Department of Health, 2006).   
 
 
2.5  Communication 
Communication is essential to everyday life and is the centre of professional practice. 
The way in which people communicate is unique and influences the quality of the 
relationships with those they interact with (Jootun & McGhee, 2011:40).  Furthermore 
Jootun and McGhee (2011:41), illustrate that this process requires a vast range of skills 
in intrapersonal and interpersonal processing, listening, observing, speaking, 
questioning, analysing and evaluating. 
 
Good communication is the foundation of safe, effective patient and family-centered 
care, whereas poor communication is often cited as the thrust for malpractice suits, non-
adherence to treatment regimens, and patient dissatisfaction (Knops & Lamba, 
2010:825).  Furthermore these authors suggest that failure to align communication 
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styles and goals can lead to miscommunication and frustration.  Additionally Williams, 
Hanson, Boyd, Green, Goldmon, Wright and Corbie-Smith (2008:1221) refer to effective 
communication as fundamental for mutual understanding, informed decision making, 
and effective delivery of health care. 
 
In a qualitative study carried out to find out barriers to effective communication across 
the primary and secondary interface, communication issues across each of the stages 
of the patient journey included content, tone, style, and format (Farquhar, Barclay, Earl, 
Grande, Emery & Crawford, 2005:363).  However most often it was the speed at which 
information was received that caused difficulties (Farquhar et al, 2005:3630).  According 
to Le-Roux (2002:41) language and culture are inextricably bound and cross-cultural 
communication is complex.  Furthermore speaking the same language does not 
guarantee effective intercultural communication. 
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Figure 2.2 The process of communication (Adapted from Jootun & McGhee, 
2011:42) 
 
The process of communication starts with the information or message that needs to be 
conveyed to another person who is referred to as receiver and the one who conveys the 
message is the sender (see figure 2.2).  The message is encoded to eliminate elements 
of confusing the receiver and thus communication takes place.  The message is then 
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decoded so that it can be well understood by the receiver and then message will be 
received (Mc Ghee, 2011:42).  The receiver of the message then sends feedback after 
receiving and understanding the message.  The process then starts all over again (Mc 
Ghee, 2011:42).  According to Bahri (2010:1067) communication may be defined as a 
two-way process that involves a sender transmitting information to a receiver with a 
declared intention or expectation.   
 
There are different channels of communication that can be used.  The message can be 
sent through face to face conversation.  That is when the sender and the receiver are at 
each other’s vicinity.  Communication can also take place by telephones or through 
video conferencing or writing of letters.  Electronic mails can also be used or faxing of 
messages or desired information that needs to be sent.   
 
 
2.6  Comprehension 
Comprehension is the first step in the critical appraisal process and involves 
understanding of terms and concepts in a report as well as identifying study elements 
and grasping the nature, significance and meaning of these elements (Burns & Groove, 
2009:602).  A satisfactory informed consent process for clinical research can be elusive 
under the best of circumstances and the prospective participants may be limited in their 
understanding of the process by poor education or serious illness (Morreim, 2004:1).   
 
According to Lidz (2006:536), adequate information (I) given to a competent individual 
(C) will yield understanding (U), and a voluntary individual (V) who understands (U) will 
make a free and rational decision (D).  This model is classic Enlightenment rationalism: 
if we are told the truth, we will be able to make rational decisions in our own best 
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interests.  The model describes the ‘‘strong’’ version of informed consent in two 
formulae: 
    I+C =U 
    V+U=D 
 
 
2.7  Therapeutic misconception 
Therapeutic misconception (TM) was first identified by Appelbaum, Roth and Lidz in 
their influential 1982 paper (Lawrence, 2008:140).  Therapeutic Misconception (TM) is 
when research participants cannot distinct between research and treatment.  Lidz 
(2006:540) posit that TM is more than a failure by a subject to understand the elements 
of research consent.  The subjects may not understand the nature of a study or the 
procedures involved but avoid attributing therapeutic intent to the research.   
 
According to Henderson, Churchill, Davis, Easter, Grady, Joffe et al (2007:1735) the 
key component of informed consent to participate in medical research is the 
understanding that research is not the same as treatment.  King, Henderson, Churchill, 
Davis, Hull, Nelson et al (2005:5) in an analysis of consent forms revealed that 
vagueness, inconsistency and overstatement may all promote confusion about what 
subjects can expect from receiving the experimental intervention.  In this case 
participants may join studies with an idea that it is therapy meanwhile it is just research, 
especially in trials that compare treatment and placebo.   
 
Conversely, understanding the goals and methods of a research project (e.g. double-
blind procedures) does not mean that subjects will not attribute therapeutic motivations 
to them (Lidz, 2006:540).  Henderson et al, (2007:1736) have documented 
misunderstanding among research participants being related to characteristics such as 
older age, lower education, and the way in which information about the study is 
conveyed.   
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2.8  Ethical considerations for IC  
According to Iltis (2004:10) the existing theoretical understanding of the ethical 
requirement to obtain IC generally is understood as a duty to respect autonomy.  That is 
the authority of persons to make decisions regarding what they will do and what will be 
done to them.   
 
The GCP guidelines stipulates that, for an Informed consent form to be used in a trial, it 
must first be approved by an Institutional Review Board (IRB) or an Independent Ethics 
Committee (IEC).  The IRB/IEC is independent body whose purpose is to ensure the 
safety and wellbeing of research participants.  After approval by the IRB/IEC, the 
investigator or a person designated by the investigator is responsible to explain the 
informed consent, both in written form and orally, in a lay language.  After receiving the 
information the research participant should be given time to consider the participation 
and if desired, discuss the participation with anyone they feel like (South Africa 
Department of Health, 2006).   
 
When signing the informed consent form, the participants attests that the information 
has been explained and that they have understood the concepts.  When the subject is 
not able to make an informed consent, the subjects’ rights can be overtaken by a legally 
acceptable representative.  This may be the case when children or psychiatric patients 
are enrolled in a trial.  After signing the form, the participant should be provided a copy.  
Since Informed consent is a process, changes may be needed during the course of the 
trial.  Any additional changes that may occur should be approved by the IRB and 
notified to the subject (South Africa Department of Health, 2006).   
 
There are ethical aspects that need to be complied with when giving informed consent 
and are as follow; 
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2.8.1 Language  
The form and the content for IC are influenced by the possibilities and limits of language 
(Marshall, 2007:31).  The misunderstanding and miscommunication about the elements 
of IC are more likely to occur when investigators and participants speak different 
languages and when IC must be translated.  In addition to the lack of equivalent or 
similar words that may be used in translation, the process of translation itself may result 
in misinterpretation of the research.   
 
According to Mills et al (2006:309), obtaining consent is a further challenge in some 
female populations and that may interfere with their understanding of the uncertainties 
that exists within clinical trials.  Furthermore Mills et al (2006:309) suggest all trial 
related information should be presented in the local language and should address 
varying levels of education in both written and oral presentation so that participants fully 
understand their rights, risks, benefits and potential benefits.  This is further supported 
by the GCP guidelines that the language used in the oral and written information about 
the trial, including the written IC form, should be non-technical, practical and 
understandable to the subject or the subject’s legally acceptable representative and 
impartial witness where applicable (South Africa Department of Health, 2006).   
 
 
2.9  Vulnerable populations  
The vulnerable populations are persons who are relatively or absolutely incapable of 
protecting their own interest through negotiations for informed consent (Tait, 2009:59).  
Those generally accepted as being vulnerable include children, prisoners, pregnant 
women, foetuses, mentally disabled persons, and economically or educationally 
disadvantaged individuals.  These populations were identified after the historical 
examples in which research subjects were exploited for the purpose of medical 
research.   
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In addition Mkandawire-Valhmu, Rice and Bathum (2009:1729) suggest that it is 
important to consider that members of lower social economic background may 
participate in research out of obligation to the researcher whom they see as privileged 
than themselves.  Furthermore Tait (2009:63) illustrates that patients with severe poorly 
controlled pain may experience limitations in autonomy and may misperceive benefits 
and risks.   
 
Vulnerable populations refers to those that are at risk of being misused in the course of 
medical research, either by coercion or a lack of knowledge, understanding or ability to 
obtain and understand that knowledge presented before them.   
 
In a study of mothers’ experiences enrolling their children in bone marrow 
transplantation, it was found out that the women were emotionally traumatized by the 
news of finding out the diagnosis of their children and they could do anything in 
desperation for their children to get help (Stevens & Pletsch, 2002 :84).  The perception 
of their medical condition that brought them to hospital was so critical and a matter of 
life and death that participation in the study was no longer a voluntary choice.  They 
compromised their right of choice as they felt that if they decline to participate it may be 
just as good as sentencing one to early death.  Furthermore Stevens and Pletsch, 
(2002:85) state that the mothers were prone to resentment, regrets and self-doubt 
particularly at turning points in the bone marrow transplant process.   
 
 
2.10  Socio economic status 
The men that participated in the Tuskegee Syphilis Experiment were typically poor and 
illiterate and this made it easier to deceive and exploit them (Sharma, 2009:256).  When 
they were recruited they were also offered various incentives such as “free physical 
examinations”, free rides to and from the clinics, hot meals on examination days, free 
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treatment for minor injuries, and a guarantee that burial stipends would be paid to their 
survivors (Sharma, 2009:256).  This is coercion since they were poor it’s obvious they 
would not miss such an opportunity for free food and free physical examinations.  The 
participants’ enrolment in this situation is evident that they did not understand the 
implications of the study but were after free medical services offered.  Their social 
circumstance had more influence in their decision making.  Thus socio-economic status 
plays a role in clinical research and can lead to misconceptions.   
 
 
2.11  IC and Culture 
In a study carried out in Botswana by Shaibu (2007:505) participants preferred to be 
interviewed together with family members who were considered to be contributing in 
their care-giving.  The participants interpreted that care giving is not an individual effort 
but a collaborative endeavour within the extended family.  According to Shaibu 
(2007:505) this view is deeply embedded in culture of Batswana people.  This can be a 
concern of compromise of confidentiality.  Moreover Frimpong-Mansoh (2007:108) 
believes that African culture places more emphases on community than the individual 
while the western values are individualistic.   
 
According to Tindana, Kass and Akweongo (2006:1) in the Kassena–Nankana district of 
Northern Ghana, local cultural values and practices such as the role of traditional chiefs, 
influence many aspect of daily life including participation in research.  Moreover in this 
society, husband’ permission is likely to influence the female’s decision to participate 
likewise in the community, if the chief gives a go ahead to the researchers to carry out 
the study (Tindana et al, 2006:5).   
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Cultural impacts are a challenge in some parts of the world when handling IC.  In a 
study carried out in Nigeria, some patients view the fact that the doctor asked them to 
make a choice as a sign of incompetence (Ezeome & Marshall, 2009:142).  Carrying out 
research in such populations will remain a challenge because IC must be choice without 
coercion.   
 
IC is mostly carried out by nurses.  In hospitals before any procedure is done on a 
patient for example operations, delivery of a baby using aid of instruments like forceps, 
an informed consent must be carried out.  When treatment is provided to the patients, 
the nurse must inform the patient before giving and it’s the responsibility of the nurse to 
answer any questions the patient may ask regarding the particular treatment.  However 
if unsure of the answers he/she can consult the doctors for assistance.   
 
 
2.12  Summary  
This chapter is an over-view of the literature on IC.  It points out the challenges that 
exist in the process of informed consent.  Furthermore the manner in which information 
is communicated and how it influence understanding as well as cultural background’ 
impact on IC.   
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CHAPTER 3
RESEARCH DESIGN AND METHODOLOGY 
 
3.1  Introduction 
This chapter provides an overview of the research methodology used in this study.  The 
description of the study design is made including its advantages and disadvantages.  
The study population, sampling method, data collection procedure are described.  
Furthermore data analysis, validity and reliability of the study and ethical consideration 
are also discussed. 
 
 
3.2  Study Design 
Burns and Grove (2009:696) describe a research design as a “blueprint for conducting a 
study that maximizes control over factors that could interfere with the validity of the 
findings” and research methodology as the “process or plan for conducting specific 
steps of the study”.   
 
The study design was descriptive and methodology was quantitative.  A survey was 
conducted to find out how well participants understood informed consent when 
participating in research. 
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3.2.1  Quantitative research 
Quantitative research is the investigation of phenomena that lend themselves to precise 
measurement and quantification, often involving a rigorous and controlled design (Polit 
& Beck, 2006:508).  Data that is quantified in quantitative research include variables 
such as weight, length, treatment outcome and gender.   
 
 
3.2.2  Descriptive Design 
Descriptive studies are used to identify phenomenon of interest, identify variables within 
the phenomenon, develop conceptual and operational definitions of variables and 
describe them (Burns & Groove, 2003:480).  In a descriptive study, no attempt is made 
to change behavior or conditions, things are measured as they are.   
 
 
3.2.3  Survey study 
Survey studies can be classified as descriptive, exploratory or comparative (LoBiondo-
Wood & Haber, 2010:198).  These studies collect detailed descriptions of existing 
variables and use the data to justify and assess current conditions to make more plans 
for improving health care practice (LoBiondo-Wood & Haber, 2010:587).  The main 
advantage of surveys is that they are inexpensive to conduct.   
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3.3  Study population and sampling 
The study was carried out in a city located in the Eastern Cape Province of South 
Africa.  Participants were recruited from clients who were participating in existing 
studies conducted at a research unit located at two hospitals in the city.  There were 
three studies taking place at the research unit during the time of data collection.  
Participants were recruited from individuals who have already consented to participate 
in one of the research unit studies.  Convenience sampling was used to select 
participants for the study.  Each newly recruited participant who agreed and gave 
consent to participate in the research unit studies, was also approached to participate in 
this study.   
 
Participants were recruited from the following studies: 
 
Study A 
Study A was a randomized controlled trial comparing the efficacy, safety and 
acceptance of the intra-uterine contraceptive device versus intramuscular depot 
progestogen contraception injection for reducing pregnancy rate.   
 
Study B 
The primary objective of study B was to explore the demographic, socioeconomic 
factors, infant feeding practices, immunisation, and micronutrient status on infant 
growth, diarrhoea as well as respiratory diseases in infants of age six weeks to nine 
months. 
 
Study C 
The primary objective of study C was to compare massaging the uterus for 30 minutes 
versus oxytocin injection in the prevention of post-partum haemorrhage. 
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3.4  Data collection Method 
A questionnaire was formulated based on the template of the World Health 
Organization's template for informed consent.  The questionnaire had both closed and 
open-ended questions.  The open ended questions allowed participants to express 
themselves freely to explain what they understood from their participation in the trial.  
Additional baseline demographic data like age and educational background were also 
collected.  The researcher and trained field workers were involved in the data collection 
process.  All the field workers were trained in good clinical practice. 
 
 
3.5  Questionnaire 
The questionnaire consisted of 32 questions divided into five categories: biographical 
data, participation, intervention, risks/benefits and rights/obligations.  The biographical 
part focused on the participants’ age, gender, education etc.  In the category of 
participation the questions considered the understanding of the purpose of the study 
and the reason for participating.  The third category, intervention, explored the 
understanding of the procedures in the particular trial.  The risks/benefits category 
focused on potential harms and whether participants expected any remuneration from 
participation.  The last category rights/obligations focused on understanding of the 
possibility to withdraw, participants’ awareness of what their signature on the consent 
form meant.  The questions were based on an informed consent form which in turn was 
based on the WHO template for what kind of information an informed consent form 
should contain.   
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3.5.1  Advantages of a questionnaire 
The questionnaires allows confidentially and anonymity (LoBiondo-Wood & Haber, 
2010:277).  Polit and Beck (2006:296) adds that anonymity may be crucial in obtaining 
information about illegal or deviant behaviours.  Questionnaire excludes personal 
opinions’ influence by data collectors on participants.  Participants are free to write what 
they want at their own pace.   
 
Generally it is quick to collect information using a questionnaire and potential 
information can be collected from a large portion of a group although it may take time to 
develop and analyse.  The data collector was able to hand out about three 
questionnaires to three participants at the same time, unlike face to face interview 
where each participant is attended to solely.   
 
The questionnaire was appropriate to use as the study was carried out mostly on 
women who were participating in the research unit studies and most of them were 
mothers with very young babies.  It gave them time to be able to concentrate on their 
children as well and continue answering the questionnaire when finished with the baby. 
 
 
3.5.2  Disadvantages of a Questionnaire 
The people with lower literacy may have difficulty to complete (LoBiondo-Wood & 
Haber, 2010:277).  Participants may forget important issues as questionnaires like other 
evaluation methods occur after the event.   
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The open-ended questions can generate large amounts of data that can take a long 
time to process and analyse.  Participants may also answer superficially, more 
especially if the questionnaire is long.  Where there is no clarity it is difficult to contact 
the participants unlike face to face interviews where one can seek clarity as the 
participant provide their views.   
 
 
3.6  Procedure 
Before participants were enrolled in their original study, the participants were given a 
hard copy of the informed consent form to read through.  Since English and Xhosa are 
the most commonly spoken languages in the Eastern Cape, the informed consent form 
was available in both languages.  The IC information was also given orally by members 
of the research team.  After time had been given to consider the participation and ask 
questions regarding any aspect of the trial, the consent form was signed.  
 
Within 48 hours, after participating in any of the 3 studies previously stated, the 
participants were asked to participate in the informed consent study.  The minimum time 
interval between enrolment in the research unit studies and the IC study was eight 
hours.  Participants were given time to consider their participation and ask questions 
regarding their participation in the informed consent study.  If they agreed to participate 
and the informed consent form was signed they were handed a questionnaire.  The 
questionnaire, containing questions regarding the original study, was then filled in by the 
participant.  The filled in questionnaire was then collected and filed in a safe place.   
 
The participant was given the opportunity to write down the answers to the open ended 
questions herself and had alternative of researcher to write down the answer.  In the 
latter case the researcher read the documented answer back to the participant to 
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ensure correctness of the recorded information.  The answers to the open ended 
questions were translated from Xhosa to English and back translated by a professional 
linguistic department to ensure accuracy of the information.   
 
 
3.7  Data Analysis 
Data analysis reduces, organizes and gives meaning to the data collected in a study 
(Burns & Groove, 2009:44).  Quantitative data was entered onto a Microsoft excel sheet 
and analysed.  Findings are presented in tables and texts, interpreted and discussed.  
The statistic test used was Chi-square to measure heterogeneity.  The common themes 
and written descriptions of findings were formulated from responses of open-ended 
questions to analyze the responses of participants.   
 
 
3.8  Reliability 
Reliability is concerned with the consistency of the measurement technique (Burns & 
Groove, 2007:364).  The reliability of the IC study was ensured by the guidance of the 
statistian who examined and approved the data collection tool.  The data collectors 
were trained research midwives of the effective care research unit who passed the GCP 
course and researcher in addition collected data.  The data collectors were also taught 
about the study and procedures of how the study should be carried out.   
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3.8.1  Reliability from data collectors  
All the research midwives had undergone Good Clinical Practice training and were 
certified.  Regular interaction of research midwives was encouraged and they were 
motivated to give correct information.   
 
 
3.9  Validity 
Validity refers to the degree to which the instrument accurately reflects the abstract 
concept being examined (Burns & Groove, 2007:365).  A pilot study was conducted to 
test the questionnaire and to check the feasibility of the study prior to commencing data 
collection of the main study.  The validity was ensured in the following manner; 
 
 
3.9.1  Face validity  
Face Validity is the verification that the instrument measures the content desired (Burns 
& Groove, 2007:540).  The research instrument was introduced to the research unit staff 
and discussed with all the research midwives.  For the purpose of the study, the 
instrument was pretested, through a pilot study, and all relevant questions were used in 
the actual study, after the removal of duplicated and unclear questions.  . 
 
 
3.9.2  Construct validity 
The questionnaire was given to five experts to confirm, face, content and criterion 
validity.  The questionnaire was first translated into Xhosa and then given to another 
translator and translated it back into English, assuring the accuracy of translation.   
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3.9.3  Content validity  
The content validity is the extent to which the method of measurement includes all the 
major elements relevant to the construct being measured (Burns Groove, 2007:535).  A 
thorough literature review was done by the researcher on all the aspects that can affect 
understanding of informed consent and a World Health Organisation (WHO) informed 
consent template was adapted to ensure that the instrument is comprehensive and 
represents a variety of knowledge in order to measure the question to be answered.  
The questions in the questionnaire were derived from its content.  The WHO template 
contains all relevant aspect that needs to be addressed to participants.   
 
 
3.9.4  External validity 
The external validity had limitations in that the sample to a large extent consisted of low 
educated people living in townships in the city.  This may make the results less reliable 
when generalizing the results to more developed parts of the world.  However the 
results can be generalized to population where participants were drawn from.   
 
 
3.9.5  Internal validity 
Internal validity / truth-value was insured by being satisfied that the participants 
accurately understood the questions and agreed with the way it was interpreted.  The 
researcher clarified the information given to her with the participant to ensure that it was 
correctly understood.   
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3.9.6  Validation of data collected 
A daily review of data collected was conducted by the researcher and forms were dated, 
coded, and signed.  The study faced a few biases; mainly information bias where by the 
participants may have answered in an attempt to please the researcher.  Data collectors 
were trained on administering of the questionnaire and what the study is about.   
 
 
3.10  Pilot Study 
A pilot study is a smaller version of a proposed study which is conducted to refine the 
methodology such as the treatment, instrument or the process of data collection (Burns 
& Groove, 2009:44).  The pilot study was conducted under similar conditions of the 
actual study.  The questionnaire was issued to a smaller group of participants to check 
for weakness and vagueness.  Only ten participants enrolled in the pilot study.  The 
outcomes of the pilot study showed that the study was feasible and all errors were 
eliminated from the questionnaire of the actual study.  The participants of the pilot study 
were not included in the analysis of the actual study. 
 
 
3.11  Limitations 
The limitation of this study included recruitment from only two maternity hospitals in one 
city, clients at other maternity units were not included in the study.  Majority of the 
population was African, Xhosa women.  Other racial groups were not well represented 
and require further investigation.   
 
Another factor that influenced the results is that the questions in the questionnaire were 
based on a template for informed consents provided by WHO, however only one of the 
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original studies consent was based on the same template.  The information on the 
duration of the original study was not included in all the three ICs of individual research 
unit studies and therefore made it impossible for the participants to give a correct 
answer.   
 
 
3.12  Ethical considerations 
This study was approved by Stellenbosch University HREC and permission to carry out 
the study was also obtained from the research unit which is based in two hospitals in 
the city.  Confidentiality was maintained.  Participants were free to decline or withdraw 
at any time and were assured that it would not compromise the care they received at 
the institution.  Number codes were used for participants.  No names were attached to 
participant’s results even during report writing.  The study was conducted according to 
the Good Clinical Practice guidelines in the conduct of Clinical Trials with Human 
participants.   
 
 
3.13  Summary  
The research design, data collection and procedures were addressed in this chapter.  
The reliability and validity of the data collection instrument were substantiated.  In the 
following chapter findings of the study results are presented.   
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CHAPTER 4
RESULTS 
 
4.1 Introduction 
In this chapter the results of the research study are presented.  The findings presented, 
report on the communication and miscommunication of informed consent in clinical 
trials.  The results of both ended questions and close ended questions are provided in 
tabular form.   
 
The sample size consisted of 170 participants from three groups of the research unit 
studies.  The sample sizes were as follows; Study A (70 participants), Study B (20 
participants) and Study C (80 participants).   
 
The Chi-square test was applied to measure heterogeneity.  The higher the Chi-square 
test the wider the differences of values or the wider the variation between groups.  The 
p-value was set out at a significant level of 0.05 and therefore p-values of less than 0.05 
were considered significant.   
 
 
4.2.  Ages of the three study groups 
The ages of the participants from all the study groups are presented in Table 4.1.  The 
research unit study groups are presented in the table.  The age of participants ranged 
from 17 to 42 years old.  The average age was 25.9 years with a standard deviation of 
5.98 years.   
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Table 4.1  Ages of three study groups 
VALUES Study A Study B Study C TOTAL 
Average age 25.9 23.7 26.5 25.9 
Std Dev 6.00 4.52 6.21 5.98 
Min age  17 18 18  
Max age 39 32 42  
NUMBER OF PARTICIPANTS 70 20 80 170 
 
 
4.3  Educational level of the participants 
According to Table 4.2, the highest level of education for the majority was secondary 
level of education (n=114).  Forty-two participants had a tertiary level of education and 
seven had primary level of education at the time of data collection.  Only one participant 
never attended school.   
 
Table 4.2  Educational level of the participants 
EDUCATION  Study A  Study B Study C TOTAL 
n (%) 
Tertiary  24 3 15 42 (24.7) 
Secondary  45 14 55 114 (67.1) 
Primary  1 3 7 11 (6.5) 
Never attended school  0 0 1 1 (0.6) 
No response  0 0 2 2 (1.18) 
TOTAL  70 20 80 170 
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4.4  Working participants before pregnancy   
The majority of the participants (n=111) were unemployed before the current pregnancy 
(see Table 4.3).  Eighty percent of study A participants were not working before the 
pregnancy.  In study B there was an equal number of people who were working before 
pregnancy and those who were not working while 56% of study C participants were not 
working before pregnancy.   
 
Table 4.3 Working participants before pregnancy 
WORK BEFORE Study A 
n (%) 
Study B 
n (%) 
Study C 
n (%) 
TOTAL 
n (%) 
No  56 (80) 10 (50) 45 (56) 111 (65.3) 
Yes  14 (20) 10 (50) 35 (44) 59 (34.7) 
TOTAL  70 20 80 170 
Test statistics Chi-squared=11.6325   p-value=0.003 
 
 
4.5  Participants in pain when obtaining of Informed Consent 
Ninety-five (55.9%) of the participants reported not being in pain during the time of 
signing an IC of the original study.  In study A, study B and study C, 14.3%, 30% and 
72.5% respectively reported not being in pain.   
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Table 4.4  Participants in pain when obtaining of Informed Consent 
IN PAIN Study A 
n (%) 
Study B 
n (%) 
Study C 
n (%) 
TOTAL 
n (%) 
No  60 (85.7) 14 (70) 21 (26.3) 95 (55.9) 
Yes  10 (14.3) 6 (30) 58 (72.5) 74 (43.5) 
No response 0 0 1 (1.25) 1 (0.6) 
TOTAL  70 20 80 170 
 
Test Statistic Chi-squared = 54.4751,  p-value = 0.00   
 
 
4.6  Participants who were given a copy of Informed Consent 
Five participants did not report whether they were provided with a copy of an IC.  A total 
of 130 (76.5%) participants indicated that they received a copy of the IC whilst 35 
(20.6%) did not.  More participants who received a copy of the IC were those who were 
participating in the study A.   
 
Table 4.5  Participants who were given copy of IC 
GIVEN A COPY  Study A 
n (%) 
Study B
n (%) 
Study C
n (%) 
TOTAL 
n (%) 
No  2 (2.9) 6 (31.6) 27 (35.5) 35 (20.6) 
Yes   68 (97.1) 13 (68.4) 49 (64.5) 130 (76.5) 
No response  0 1 4 5 (2.9) 
TOTAL   70 20 80 170 
Test Statistic Chi‐squared = 24.6505  p‐value = 0.001 
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4.7  Participants who were given opportunity to discuss participation 
with partner 
According o Table 4.6, four participants did not indicate if they were given the 
opportunity to discuss with the partner or not.  Approximately half (49.4%) were not 
given opportunity to discuss participation with their partners.  The study C group had a 
much lower proportion (n=24) of people who had opportunity to discuss the IC of the 
original study with partner.   
 
Table 4.6 Participants who were given opportunity to discuss participation 
with partner 
OPPORTUNITY TO DISCUSS 
PARTICIPATION  
Study A 
 
Study B
 
Study C
 
TOTAL 
n (%) 
No  23 8 53 84 (49.4) 
Yes   47 11 24 82 (48.2) 
No response  0 1 3 4 (2.4) 
TOTAL   70 20 80 170 
Test Statistic Chi-squared = 19.6031  p-value = 0.0001   
 
 
4.8  The reasons why subjects agreed to participate in the studies  
Majority of the participants (n=144) had knowledge of why they agreed to participate in 
the original studies.  Only 8.8% did not know why they agreed to participate.  The type 
of study influenced why the participants agreed to participate in the three studies.  
There was a wide variation on responses between the groups (see Table 4.7).   
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Table 4.7  The reasons why subjects agreed to participate in the studies  
WHY AGREED  Study A 
 
Study B
 
Study C
 
TOTAL 
n (%) 
Don’t know  4 3 8 15 (8.8) 
Knowledge   39 10 17 66 (38.8) 
Treatment given  23 3 36 62 (36.5) 
Other reasons  1 2 13 16 (9.4) 
No response  3 2 6 11 (6.5) 
TOTAL   70 20 80 170 
Test Statistic Chi-squared = 70.4764  p-value = 0.00  
 
 
4.9  Participants’ knowledge of the purpose of the studies 
According to Table 4.8, the participants who did not have knowledge of the purpose of 
the original study were more than half (57%).  Among the participants from study B, only 
five gave a closer answer.  A total of 35 from study A also gave a closer answer as well 
as 26 participants from study C.  None of the participants gave a correct answer.   
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Table 4.8  The purpose of the studies participants enrolled in 
PURPOSE OF THE  
ORIGIONAL STUDY 
Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
Baby’s health 0 5 2 7 (4.1) 
Don’t know 13 1 17 31 (18.2) 
Easy pain 0 0 4 4 (2.3) 
Family planning 35 0 0 35 (20.6) 
Reduce bleeding 0 1 26 27 (15.9) 
No response 22 13 31 66 (38.8) 
TOTAL  70 20 80 170 
 
 
4.10  Reasons why participants qualified to participate in the studies 
The participants had no knowledge why they enrolled in the studies.  Thirty-two (18.8%) 
participants did not respond while 135 (79.4%) gave uninformative responses.  Only 
three (1.8%) participants from study A had knowledge of why they qualified.  All three 
participants stated that it was because of their age.  It is correct to say they qualified 
because of their age, as it was one of the inclusion criteria of the original studies.   
 
 
4.11  The responsibility of participants during process of study. 
The majority of the participants did not have knowledge of their responsibilities.  A total 
of 73 (42.9%) participants gave uninformative responses, 45 (26.5%) indicated that they 
did not know their responsibilities and the rest (13.5%) did not respond.  Only 29 
(17.1%) participants had knowledge of their responsibilities, which was to cooperate 
and understand (see Table 4.9). 
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Table 4.9  The responsibility of participants during process of study. 
RESPONSIBILITY Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
Cooperate 9 2 12 23 (13.5) 
Don’t know 26 1 18 45 (26.5) 
Uninformative 29 12 32 73 (42.9) 
Understand 4 0 2 6 (3.5) 
No response 2 5 16 23 (13.5) 
TOTAL  70 20 80 170 
 
 
4.12  Informed of duration of study 
Ninety-four (55.3 %) participants indicated that they were informed about the duration of 
the study.  However information about the total duration of the original studies was not 
included in the IC forms of all the three original studies of the research unit.  Sixty-seven 
(39.4%) participants indicated that they were not informed.   
 
Table 4.10    Informed of duration of study 
DURATION OF STUDY Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
No 18 9 40 67 (39.4) 
Yes 50 10 34 94 (55.3) 
No response 2 1 6 9 (5.3) 
TOTAL  70 20 80 170 
Test Statistic Chi‐squared = 11.3903    p‐Value = 0.0034     
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4.13  If informed of duration of study, mention when it will end 
Sixty-two (36.5%) participants did not respond to the question pertaining to whether 
they were informed of when the study would end.  A total of 108 (63.5%) participants 
gave various answers.  However the information of how long the study will take was not 
provided in all IC forms of the three studies.   
 
 
4.14  The duration of participation on the studies 
According to Table 4.11, thirty-two (18.8%) participants stated that they did not know 
the duration of their participation in the study.  Fourteen (8.2%) participants gave 
uninformative responses and 32 (18.8%) did not provide response.  Only 50 (29.4%) 
participants had knowledge of the duration of their participation in the studies, and they 
were all participants from study A.   
 
Table 4.11  The duration of participation on the studies 
DURATION Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
1 Visit 13 0 0 13 (7.6) 
1 year 40 0 0 40 (23.5) 
5-30 min 0 6 23 29 (17.1) 
Don’t know 5 1 26 32 (18.8) 
Uninformative 2 5 7 14 (8.2) 
Many visits 10 0 0 10 (5.9) 
No response 0 8 24 32 (18.8) 
TOTAL  70 20 80 170 
 
Stellenbosch University http://scholar.sun.ac.za
56 
 
4.15  Awareness of different treatments 
A total of 86 (50.6%) participants responded that they were aware of the different 
treatments.  Sixty –nine participants indicated that they were not aware of the different 
treatments.  Fifteen (8.8) participants did not provide response if they were aware of the 
different treatments of the original study.   
 
Table 4.12      Awareness of different treatments 
AWARENESS OF  
DIFFERENT TREATMENT 
Study A 
 
Study B
 
Study C
 
TOTAL 
n (%) 
No  8 8 53 69 (40.6) 
Yes   62 3 21 86 (50.6) 
No response   9 6 15 (8.8) 
TOTAL   70 20 80 170 
Test Statistic Chi-Squared = 56.5838  p-value = 0.00    
 
 
4.16  The different treatment options or interventions  
Sixty-four (37.6%) participants had the knowledge of the different treatments available.  
Fifty-seven participants (33.5%) were from study A and seven participants (4.1%) from 
study C.  A total of 106 (62.4%) participants did not have knowledge of the treatment 
options, including 86 (50.6%) participants that did not provide a response (see Table 
4.13).   
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Table 4.13  The different treatment options or interventions  
INTERVENTIONS  Study A
 
Study B
 
Study C
 
TOTAL 
n (%) 
Loop ,injection  57 0 0 57 (33.5) 
Supplement, bottle or cup feeding  0 0 0 0 (0) 
Massage/no massage  0 0 7 7 (4.1) 
Incorrect answer  5 2 13 20 (11.8) 
No response  8 18 60 86 (50.6) 
TOTAL   70 20 80 170 
 
 
4.17  Randomization  
None of the participants knew anything about the chances of receiving any of the 
treatments.  Uninformative answers were provided.   
 
 
4.18  Benefits 
The majority of participants (n=165) did not have knowledge of the possible benefits 
available of the original study.  Thirty-nine participants indicated that they did not know 
the benefits.  A total of 18 participants did not respond.  Hundred and forty-seven 
(86.5%) participants gave uninformative responses.  Only five participants had 
knowledge of the possible benefits available of the three studies.   
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4.19  Awareness of risks related to treatments or procedures 
According to Table 4.14, 128 (75.3%) participants indicated that they had no knowledge 
of risks related to the treatments or procedures.  A total of thirty-six (21.2%) participants 
indicated that they were aware.   
 
Table 4.14    Awareness of risks related to treatments or procedures 
AWARENESS OF  
TREATMENT RELATED RISK 
Study A 
 
Study B
 
Study C
 
TOTAL 
n (%) 
No  48 10 74 128 (75.3) 
Yes   22 10 4 36 (21.2) 
No response  0 0 6 6 (3.5) 
TOTAL   70 20 80 170 
Test Statistic Chi-squared = 31.6589 p-value =0.00     
 
 
4.20  Risks related to the original study 
Hundred and thirty-seven (80.6%) participants did not respond to the question 
pertaining to mentioning of the possible study related risks.  However 36 (21.2%) 
participants stated in the previous question that they were aware of the study related 
risks but a lesser number (n=33) responded to the question.  A total of nine participants 
from the 33 participants had knowledge of the possible risks related to the study.   
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4.21.  Alternatives to participation 
A total of 79 (46.5%) participants indicated that there were no alternatives available if 
one disagree to participate.  Thirty-three (19.4%) participants had no knowledge of 
alternatives available if they disagree to participate.  Only four (2.4%) participants had 
knowledge of the alternatives to participation if they disagree to participate in research 
unit studies.  Twenty-two (12.9%) did not respond.  Two (1.2%) participants stated that 
they did not understand.  Thirty (17.6%) participants gave uninformative response.   
 
 
4.22.  Rights to withdrawal from the studies 
Hundred and twenty-eight (75.3%) participants indicated that if they chose to withdraw 
from the studies there would be no consequences while thirty-two (18.8%) indicated that 
there would be consequences.  Ten (5.9%) participants did not respond.   
 
Table 4.15  Rights to withdrawal from the studies 
ANY CONSEQUENCES 
OF WITHDRAWAL 
Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
No 56 12 60 128 (75.3) 
Yes  14 7 11 32 (18.8) 
No response  1 9 10 (5.9) 
TOTAL  70 20 80 170 
 
Test Statistic Chi-squared = 4.2698  p-value = 0.1183 
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4.23  The consequences of withdrawal from the studies 
Hundred and thirty-six (80%) participants did not provide response as to whether there 
would be any consequences if one chose to withdraw from the study.  A total of 34 (20) 
participants responded but however the responses they gave were uninformative.   
 
 
4.24  Any money received from the researcher  
According to Table 4.16, 168 (98.8%) participants stated that they did not receive 
money from researcher.  Only one (1.6%) participant stated that she received money 
from researcher.  The participant did not provide the reason why she accepted the 
money and how much it was.  There is no indication if it was related to enrollment of the 
study or personal.  One participant (1.6%) did not respond.   
 
Table 4.16  Any money received from the researcher  
RECEIVED MONEY Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
No 70 19 79 168 (98.8) 
Yes  0 1 0 1 (0.6) 
No response 0 0 1 1 (0.6) 
TOTAL  70 20 80 170 
 
 
4.25  Trial related injuries 
The participants were asked if they understand what assistance is available if they 
sustained an unexpected trial related injury.  Twenty–five (14.7%) participants did not 
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respond.  A total of (n=127) stated that they cannot recall.  Only 18 (%) had knowledge 
of what will happen in an unlikely event.   
 
 
4.26  Confidentiality 
A total of twenty-two (12.9%) participants stated that nobody would have access to their 
personal information the researcher had about them.  Twenty-four (14.1%) participants 
did respond to the question pertaining to who would have access to the information the 
researcher had about them.  A total of 51(30%) stated that the medical team would 
have access to their information.  Forty-eight (28.2%) participants stated that they did 
not have knowledge of who would have access to the information that they provided to 
the researcher.  Twenty-five (14.7%) participants provided various responses which 
were incorrect.   
 
 
4.27  The use of gathered information at the end of the study   
Eighty-two (48.2%) participants stated that they did not have knowledge of what would 
be the use of the gathered information.  According to Table 4.17, 62 (36.5%) provided 
uninformative answers.  A total of 21 (12.4%) did not respond.  None of the participants 
had knowledge of what would be the use of gathered information.   
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Table 4.17  The use of gathered information at the end of the study   
INFORMATION GATHERED Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
Confidential 4 0 1 5 (2.9) 
Don’t know 30 6 46 82 (48.2) 
Uninformative 32 11 19 62 (36.5) 
No response 4 3 14 21 (12.4) 
TOTAL 70 20 80 170 
 
 
4.28  The person to contact for additional questions 
According to Table 4.18, 61(35.9%) participants indicated that the research team could 
be contacted for additional questions, and additional 39 (22.9%) participants listed the 
medical staff (nurse and doctor).  In total, more than half of the participants had 
knowledge of who to contact.  Thirty-six (21.2%) participants did not respond.  Three 
(1.8%) participants stated that nobody could be contacted for additional questions.  Ten 
(5.9%) participant’s responses were uninformative.  Twenty one (12.4%) participants 
stated that they did not have knowledge of who to contact.   
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Table 4.18  The person to contact for additional questions 
CONTACT PERSON Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
Don’t know 2 0 19 21 (12.4) 
Medical staff 33 2 4 39 (22.9) 
Nobody 0 0 3 3 (1.8) 
Research team 29 8 24 61 (35.9) 
Uninformative 2 2 6 10 (5.9) 
No response 4 8 24 36 (21.2) 
TOTAL  70 20 80 170 
 
 
4.29  The meaning of signature on IC 
The majority of participants 115 (67.6%) stated that they understood what their 
signature on the IC of the original study meant.  Less than half (27.6%) of the 
participants stated that they did not have knowledge of what their signature on the IC 
meant.  Eight (4.7%) participants did not respond.   
 
Table 4.19  The meaning of signature on IC 
MEANING OF 
SIGNATURE 
Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
No 9 10 28 47 (27.6%) 
Yes  58 9 48 115 (67.6%) 
No response 3 1 4 8 (4.7%) 
TOTAL  70 20 80 170 
Test Statistic Chi-squared = 15.305  p-value = 0.0005 
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4.30  Explanation of meaning of signature on informed consent form 
Twenty-six (15.3%) participants had knowledge that their signature on the IC forms 
means their agreement to participate.  Fifty-nine (34.7%) did not respond.  Three (1.8%) 
participants responded that they did not know what it meant.  The majority (144) did not 
have knowledge of what their signature on the IC form meant.  These results contradict 
the total of 115 participants that indicated that they understand what their signature 
meant.   
 
Table 4.20  Explanation of meaning of signature on informed consent form 
EXPLANATION OF 
SIGNATURE 
Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
Agreement 18 2 6 26 (15.3) 
Don’t know 0 0 3 3 (1.8) 
Family planning 10 0 0 10 (5.9) 
Uninformative 29 7 17 53 (31.2) 
Uterine massage 0 1 18 19 (11.2) 
No response 13 10 36 59 (34.7) 
TOTAL  70 20 80 170 
 
 
4.31  Information given prior participation in the trials was sufficient or not 
A total of 146 (85.9%) participants indicated that the information provided in the IC of 
the research unit studies was sufficient to decide to participate in the studies.  Four 
(2.4%) participants did not respond.  Only twenty participants stated that the information 
provided was insufficient.  The responses of sufficiency of information was highly 
significant (p=0.0002).   
Stellenbosch University http://scholar.sun.ac.za
65 
 
Table 4.21  Information given prior participation in the studies was 
sufficient or not 
INFORMATION SUFFICIENT  
FOR DECISION 
Study A 
 
Study B 
 
Study C 
 
TOTAL 
n (%) 
No 0 4 16 20 (11.8%) 
Yes  70 16 60 146 (85.9%) 
No response   4 4 (2.4%) 
TOTAL  70 20 80 170 
Test Statistic Chi-squared = 16.5976 p-value = 0.0002 
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CHAPTER 5
DISCUSSIONS, CONCLUSION AND RECOMMENDATIONS 
 
5.1  Introduction 
This chapter discusses the findings of this study.  The conclusion and recommendations 
are provided.  Obtaining an informed consent is an important ethical procedure in the 
process of a clinical trial.  However, it is obvious that it has its limitations as observed in 
this study.   
 
 
5.2  Age 
The total average age of the study participants was 25.9 years.  The studies at the 
research unit were mostly on reproductive health, and women of child bearing age 
participated.  This explains the average age in this study.  According to Kripalani, 
Bengtzen, Henderson, and Jacobson (2008:13) older age can adversely affect consent 
comprehension.  However in this study age did not play a major role, consent was 
poorly understood across all ages (see annexure A).   
 
 
5.3  Education 
Level of education has been associated with understanding and comprehension of 
information.  Sudore et al (2003:871) reported that lower literacy participants were at 
risk for poor comprehension of information.   
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The majority of participants in this study had secondary level of education.  The literacy 
level of the study population was therefore average.  Tertiary level consisted of 42 
(24.7%) participants, secondary level had 114 (67.1%) participants and participants who 
had a primary level participants were 11 (6.5%).  Kripalani et al, (2008:17) found that 
literacy was considerably associated with comprehension of consent and privacy of 
information, despite taking recommended steps to simplify the information.  Additionally 
the participants of a higher educational level comprehend information better than those 
with lower grade (Kripalani et al, 2008:17).  In overall the understanding of IC was very 
low.  The questionnaire was poorly answered across all the educational levels.   
 
Participant’s responses showed a poor understanding of IC and this may be related to 
several factors.  The most important factor is the language barrier between English 
speaking staff and participants whose parental tongue is Xhosa.  Sudore et al 
(2003:871) identified that literacy and language barriers appear to be important 
determinants of comprehension of information.   
 
To eliminate the language problem, questionnaires and IC’s, were available in both 
Xhosa and English.  When further oral explanation was needed the communication 
problem became obvious for non Xhosa speaking research staff, however Xhosa 
speaking staff were called to assist.  
 
 
5.4  Pain 
Pain can hinder understanding and impact on recalling of information depending on its 
severity.  It has been illustrated by Tait (2009:63) that patients with severe poorly 
controlled pain may experience limitations in autonomy and may misperceive benefits 
and risks.  A total of 74 (43.5%) participants were in pain during the time of obtaining 
consent.  That might have had an impact on their understanding and recall of 
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information.  Study C participants received IC of the original study in the labour ward.  
According to Jamieson, O’Sullivan, Maupin, Cohen, Webber, Nesheim, Lampe, Garcia, 
Lindsay and Bulterys, (2003:890), an informed consent process during labour, is 
difficult, physical and psychologically demanding.  The women’s attention and energies 
are mostly focused on the anticipated delivery and in most instances alleviation of pain.   
 
 
5.5  Vulnerable population 
The participants of study C were recruited while in labour.  This might have influenced 
their patience to try and listen to the researcher and make an informed decision before 
joining the study.  When taking note of the question that needed participants to explain 
what their signature meant on the IC, only 6 (7.5%) out of 80 participants from study C 
responded.  A total of 74 (92.5%) out of 80 participants of study C could not give the 
appropriate answer.  Pregnant women fall under the vulnerable populations. According 
to Tait (2009:63) the patient in severe poorly controlled pain may experience limitations 
in autonomy and may misperceive benefits and risks.  The discomfort of labour pains 
might have influenced them to accede to study participation (Tait, 2009:70).   
 
 
5.5.1  Socio-economic status 
A total of 65.3% of the study population was unemployed before pregnancy.  
Employment was also used as an indicator of economic status.  It has been 
documented that men that participated in the Tuskegee Syphilis Experiment were 
typically poor and illiterate and this made it easier to deceive and exploit them (Sharma, 
2009:256).  According to Mill et al (2006:308) women in poorer countries often lack 
formal education and may not understand the uncertainty or the risk that exists within 
clinical studies.  In those communities mostly men are the ones responsible for 
providing for the family.  Additionally it is important to consider that members of lower 
socio-economic strata may participate in research out of obligation to please the 
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researcher, who they see as possessing greater power and privilege than themselves 
(Mkandawire-Valhmu, 2009:1729).   
 
 
5.6  Communication and Miscommunication  
The information about the duration of the study was not included in all the three studies 
of the research unit informed consent forms.  Some of the research midwives informed 
the participants verbally about the duration of the studies after being queried.  Therefore 
it was impossible for the participants to know if uninformed.  The poor understanding of 
certain questions may not always be due to poor understanding but rather the 
consequence of poorly communicated information.  King et al (2005;6), in their analysis 
of consent forms reported that vagueness, inconsistency and overstatement may all 
promote confusion about what subjects can expect from receiving the experimental 
intervention.  The majority of the participants (n=146) believed that the information given 
prior to participation was sufficient to make an educated decision but somehow it 
contradicts with the majority of questions which were poorly answered.  However the 
participants acknowledged that information was sufficient.  According to GCP guidelines 
(Department of Health, 2006) it is the responsibility of the researcher to make 
interaction between the participants, fruitful in a way that the participant attains 
understanding desired to make up an informed decision.   
 
 
5.7  Comprehension of information 
None of the participants knew anything about the chances of receiving any of the 
treatments.  In general the participants did not understand randomisation.  According to 
Cahana and Hurst (2008:448) subjects are more likely to misunderstand certain aspects 
specific to research such as randomization or double-blind design.  Randomization is 
Stellenbosch University http://scholar.sun.ac.za
70 
 
quite complex for participants to understand, even though it was explained simply.  
Participants thought they had a choice of one of the treatments.  In the recruitment of 
Study A, most participants were excluded because they requested for IUCD before 
randomization.  The participants thought they could make a choice between the two 
treatments due to the misunderstanding of randomization. 
 
 
5.8  Rights and obligations of participants 
Hundred and nineteen, (70%) participants did not have an idea who would have access 
to the information the researcher had about them.  This did not stop them from deciding 
on joining the research study.  Participants were not concerned about the extent of 
confidentiality that they were entitled to.  According to Mallardi, (2005:313), in the early 
times the relationship between doctor and patient was consolidated, it was based upon 
two very definite criteria.  These include the professional duty of the physician to do 
what is best for the patient and the duty of the patient to completely accept the 
physician's decisions and intervention.  The patients’ doctors felt it was their duty to 
guide patients and make decisions as they viewed patients as ignorant and not 
interested in explanations concerning therapeutic effects (Mallardi, 2005:313).   
 
 
5.9  Therapeutic Misconception 
Some participants took part in the studies for therapeutic reasons and did not 
understand the nature of research.  One participant eluded her participation in the study 
to easing of pain and preventing bleeding.   
 
According to Appelbaum, Lidz and Grisso (2004:1) the participants frequently appear to 
overestimate the likely benefits of entry into research studies and underestimate risks,  
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to be confused about the nature of randomized assignment and generally to conflate 
research with ordinary treatment.  Furthermore Appelbaum et al (2004:1) suggest that 
therapeutic misconception is not equivalent to simple failure to understand the nature 
and purpose of the research study or the procedures involved.  The participants may fail 
to understand these aspects of the study without mistakenly attributing therapeutic 
impact to them.  
 
The participants may understand the purpose and nature of the study but that does not 
mean they won’t enrol in the studies without relating them to therapeutic intent.  Some 
participants might have joined the study as a result of desperation for help.  One of the 
participants responded that she joined the study “for pain relief” while another one’s 
response was “I needed help”.  In a study by Stevens and Pletsch (2002:84) the parents 
of children with leukemia who had to undergo bone marrow transplant, the word study 
didn’t mean anything to them.  One of the mother’s responses was “all I wanted was 
some way to get rid of the leukemia, so study or no study it does not matter, treat her 
and keep her alive” (Stevens & Pletsch, 2002:84).   
 
 
5.9.1  Cosmetic 
Some participants agreed to sign the informed consent of the original study for cosmetic 
reasons.  One of the participants of Study C’s response to the question pertaining to 
why she agreed to participate was “because I wanted a massage”.  This shows she was 
enrolling in the study for cosmetic intent, of a massage.  The participant had a different 
perception or understanding of the IC of the study.  Study C used deep subcutaneous 
massaging of the uterus to stimulate contractions and stop blood flow.  The participant’s 
misunderstanding of the purpose of the study might have been due to the manner in 
which the consent information was communicated or misunderstanding the research 
staff.  In a study of analysis of 321 gene transfer research consent forms, it was 
reported that most participants were not given clear and unambiguous information about 
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potential benefits (King et al, 2005:5).  According to Kimmelman (2007:36) research 
subjects mistakenly believe that research projects will directly benefit them.  This is 
referred to as therapeautic misconception.   
 
 
5.9.2  Socialization 
Participants’ involvement in the research unit studies by some was seen as a means of 
socialization, not understanding the main aim of the study which all research 
participants must consider before giving consent to join the research studies.  One of 
the participants when asked the purpose of the study, her response was “I think is to 
socialize with people and to know me and my baby”.  Similarly Kimmelman (2007:36), 
suggest that research subjects mistakenly believe that research projects directly benefit 
them.   
 
 
5.10  Provision of informed consent for the three studies 
The data collectors were GCP trained research midwives working at the research unit.  
The research unit holds an annual research methods course for all the employees and 
any other interested individuals can attend.  The course is comprehensive to ensure the 
employees understand the conduct of clinical trials and procedures.  The operational 
manuals of the studies are explained to the research team and workshops are held 
before initiations of the studies.  The research unit holds meetings every second week 
for discussion of progress of all studies taking place.  The data collectors were free to 
consult the Principal Investigator on site for any uncertainties.   
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5.11  Conclusion 
The aim of this study was to assess the understanding of information communicated to 
trial participants by means of an informed consent form.  A signed informed consent 
does not guarantee that the participant has understood the information given and also 
pain significantly decreases a participant’s ability to comprehend information.  However 
no matter which parameter we look at, the overall understanding is very poor. 
 
The informed consent process is the key tool for which the ethical aspects of clinical 
trials rely on.  The need of developing this tool is clearly evident after reading the results 
of this study.  The conditions under which this survey was made must be taken into 
account when applying the result to other populations.  Some of the women who 
participated in the three studies were in pain.  Being in such a state might have led to 
participants unconditionally putting their trust in research unit personnel.  In spite the 
overall low understanding more than 80 % considered that the information given prior 
the original study was sufficient to make an educated decision.  This may indicate that it 
is a difficult task to evaluate the process of informed consent in a fair way.   
 
The questionnaire of the IC study contained too many questions.  This made the 
process of completing the questionnaire to be time consuming.  All questions were 
important questions.  The reason for the questionnaire being so comprehensive was to 
increase the reliability and to cover all aspects in the WHO template for what 
information an IC form should contain.  
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5.11  Recommendations 
The existing methods of communicating and obtaining of an informed consent seem to 
be insufficient for participants to make an informed decision.  A new approach with more 
interactive features such as combination of audiovisual techniques might increase the 
possibilities of understanding.  Recall might be improved if participants are provided 
with a video to watch prior to administration of a written consent.  One is likely to 
remember what is seen than what is only heard or read.  Administering of pamphlets 
with pictures and extensive teaching with posters prior to handing out of informed 
consent information leaflets also might be of help. 
 
Enhanced consent documents should be provided at a lower level to accommodate 
lower literacy level participants.  In addition, materials should be relatively short, clearly 
organized with subheadings, illustrated, and written with straight forward vocabulary. 
 
In labour a woman is under very strong pain.  This might have an effect on her 
conception of information provided during this period.  It might be more ideal to provide 
most of the information during ante-natal classes than during labour. 
 
Closer monitoring of the informed consent process may increase the will of researchers 
to conduct this process more rigorously.  Participants of research must be given ample 
time to read and understand informed consent.  Providing participants with information 
leaflet to take home to discuss with family members or friends before they join studies 
or alone, freely with no pressure of delaying data collectors is recommended.   
The results indicated some gaps that exist during the process of obtaining consent.  
There may have been recall bias as some answers were not satisfactorily attempted.   
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ANNEXURES A 
Annexure Additional tables 
Comparison of Age, Educational Level, Pain if they affect understanding 
Selective comparison was done and the aim was to have homogenous groups to 
compare.  The three variables, which are pain, educational level and age, were 
correlated with the ability to answer question pertaining to the knowledge of purpose of 
conducting the studies the participants enrolled in.   
 
Explanation of study purpose:  Study A 
 
Age did not play a major role in the reason comparing the average within the study A 
participants.  
 
 
 
 
VALUES CONTRACEPTIVES DON’T 
KNOW 
FAMILY 
PLANNING 
NO 
RESPONSE 
TOTAL 
Count of Age 8 13 27 22  70 
Average of Age 24.13 27.31 25.74 25.86 25.89 
Std Dev of Age  4.61 5.47 5.57 7.30 6.00 
Min of Age 18 17 18 17 17 
Max of Age 31 36 37 39 39 
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Explanation of study purpose: Study B 
 
Age did not play a major role in the reason comparing the average within the study B 
participants.  
 
Explanation of study purpose: Study C 
 
Age did not play a major role in the reason comparing the average within the C study 
participants. 
 
 
VALUES BABY’HEALTH AND 
FEEDING 
DON’T 
KNOW 
REDUCE  
BLEEDING 
NO 
RESPONSE 
TOTAL 
Count of Age 5 1 1 13 20 
Average of Age 23.80 29.00 23.00 23.31 23.70 
Std Dev of Age  5.54 0 0 4.42 4.52 
Min of Age 19 29 23 18 18 
Max of Age 32 29 23 32 32 
VALUES  BABY’S 
HEALTH & 
FEEDING 
DON’T 
KNOW 
EASE 
PAIN  
 
REDUCE 
BLEEDING 
UTERUS 
IN PLACE 
LITTLE 
BLEEDING 
NO 
RESPO‐
NSE 
TOTAL
Count of 
Age 
2 17 3 14 6 6 31 79 
Average of 
Age 
32.50 24.71 24.00 26.00 32.00 31.33 25.68 26.54 
Std Dev of 
Age  
0.71 5.60 3.46 6.18 6.54 5.32 6.16 6.21 
Min of Age 32 18 22 18 24 25 18 18 
Max of Age 33 37 28 37 40 39 42 42 
Stellenbosch University http://scholar.sun.ac.za
83 
 
Tertiary educational level; explaining purpose of the study-Study C 
VALUES CONTRACEPTIVE DON’T 
KNOW 
FAMILY 
PLANNING 
NO 
RESPONSE 
TOTAL 
Count of Age 5 3 10 6 24 
Average of Age 25.80 25.00 24.50 25.67 25.13 
Std Dev of Age 3.96 4.00 5.32 8.29 5.52 
Min of Age 22 21 20 19 19 
Max of Age 31 29 34 39 39 
 
 
Secondary educational level; explaining purpose of the study-Study A 
VALUES CONTRACEPTIVE DON’T 
KNOW 
FAMILY 
PLANNING 
NO 
RESPONSE 
TOTAL 
Count of Age 2 10 17 16 45 
Average of Age 18.50 28.00 26.47 25.94 26.27 
Std Dev of Age 0.70 5.83 5.75 7.19 6.33 
Min of Age 18 17 18 17 17 
Max of Age 19 36 37 37 37 
 
 
4.38  Tertiary educational level; explaining purpose of the study-Study C 
VALUES DON’T KNOW EASE PAIN UTERUS IN 
PLACE/LITTLE 
BLEEDING 
NO 
RESPONSE 
TOTAL 
Count of Age 5 1 1 8 15 
Average of Age 28.00 22.00 32.00 30.13 29.00 
Std Dev of Age 6.16 0 0 7.99 6.93 
Min of Age 22 22 32 20 20 
Max of Age 37 22 32 42 42 
 
Stellenbosch University http://scholar.sun.ac.za
84 
 
Secondary educational level; explaining purpose of the study-Study C 
VALUES BABY’S 
HEALTH 
& 
FEEDING 
DON’T 
KNOW 
EASE 
PAIN 
REDUCE 
BLEEDING 
UTERUS 
IN 
PLACE 
LITTLE 
BLEEDING 
NO  
RESPONSE 
TOTAL 
Count of 
Age 
1 11 2 12 6 3 19 54 
Average 
of Age 
32 22.91 25.00 26.25 32.00 28.67 24.53 25.80 
Std Dev 
of Age 
0 4.99 4.24 6.08 6.54 5.51 4.64 5.75 
Min of 
Age 
32 18 22 18 24 25 18 18 
Max of 
Age 
32 34 28 37 40 35 38 40 
 
 
Explaining purpose of the study: Study A participants NOT in pain  
 
 
 
 
 
VALUES CONTRACEPTIVES DON’T 
KNOW 
FAMILY 
PLANNING 
NO 
RESPONSE 
TOTAL 
Count of Age 5 12 23 20 60 
Average of Age 22.20 27.42 26.00 25.60 25.83 
Std Dev of Age  4.32 5.70 5.49 7.32 6.12 
Min of Age 18 17 18 17 17 
Max of Age 29 36 37 39 39 
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Explaining purpose of the study: Study A participants IN pain 
 
Explaining purpose of the study:Study C participants NOT pain 
VALUES BABY’HEALTH 
& FEEDING 
DON’T 
KNOW 
REDUCE 
BLEEDING
UTERUS IN 
PLACE/LITTLE 
BLEEDING 
NO 
RESPONSE 
TOTAL
Count of Age 1 3 7 2 8 21 
Average of Age 32.00 22.33 25.29 31.50 26.00 26.05 
Std Dev of Age 0 3.21 7.30 0.71 7.07 6.45 
Min of Age 32 20 18 31 18 18 
Max of Age 32 26 37 32 42 42
 
Explaining purpose of the study: Study C participants IN pain 
VALUES BABY’S 
HEALTH & 
FEEDING 
DON’T 
KNOW 
EASE 
PAIN 
REDUCE 
BLEEDING 
UTERUS 
IN PLACE 
LITTLE 
BLEEDING 
NO 
RESPONSE 
TOTAL 
Count of 
Age 
1 14 3 7 6 3 23 57 
Average 
of Age 
33 25.21 24.00 26.71 32.00 30.00 25.57 26.58 
Std Dev 
of Age 
0 5.95 3.46 5.31 6.54 7.81 5.98 6.12 
Min of 
Age 
33 18 22 18 24 25 18 18 
Max of 
Age 
33 37 28 31 40 39 42 42 
VALUES CONTRACEPTIVES DON’T 
KNOW 
FAMILY 
PLANNING 
NO 
RESPONSE 
TOTAL 
Count of Age 3 1 4 2 10 
Average of Age 27.33 26.00 24.25 28.50 26.20 
Std Dev of Age  3.51 0 6.70 9.19 5.51 
Min of Age 24 26 19 22 19 
Max of Age 31 26 34 35 35 
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Explaining purpose of the study: Study B participants IN pain 
VALUES DON’T KNOW NO RESPONSE TOTAL 
Count of Age 1 5 6 
Average of Age 29.00 21.20 22.50 
Std Dev of Age 0 3.49 4.46 
Min of Age 29 18 18 
Max of Age 29 27 29 
 
Explaining purpose of the study: Study B participants NOT in pain 
 
 
 
 
 
 
VALUES BABY’HEALTH AND 
FEEDING 
 REDUCE  
BLEEDING 
NO 
RESPONSE 
TOTAL 
Count of Age 5  1 8 14 
Average of Age 23.80  23.00 24.63 24.21 
Std Dev of Age  5.54  0 4.63 4.61 
Min of Age 19  23 20 19 
Max of Age 32  23 32 32 
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STELLENBOSCH UNIVERSITY 
FACULTY OF HEALTH SCIENCES, DIVISION OF NURSING 
Site Number  Study Number   
Informed Consent Study   
Thank you for agreeing to participate in our Informed Consent study, which involves your understanding 
of the informed consent process.  
Uvavanyo lweMvume ecingisisiweyo 
Enkosi ngokuvuma ukuthatha inxaxheba kuphando lwethu olumalunga neMvume ecingisisiweyo, equka 
ukuqonda kwakho inkqubo yemvume ecingisisiweyo. 
 
Biographical Data 
1. How old are you?  
2. What is the highest education level that 
you have completed?  
Please tick the box. 
Tertiary level      
Secondary level     
Primary level      
Never attended school     
Other     
…………………………………………. 
3.  Have you been working in the year 
before you fell pregnant? 
      
  Yes  No  
1. Mingaphi iminyaka yakho?  
2. Leliphi inqanaba eliphezulu lemfundo 
oligqibileyo?  
Korekisha ibhokisi. 
-Inqanaba lemfundo ephezulu    
Inqanaba lemfundo  
-yamabanga aphakamileyo     
Inqanaba lemfundo  
-yamabanga asezantsi    
Andizange ndaya esikolweni     
-Okunye     
………………………………………………… 
3.  Ubuphangela kunyaka ongaphambi 
kokuba ukhulelwe? 
      
  Ewe  Hayi  
Stellenbosch University http://scholar.sun.ac.za
88 
 
4. What work were you doing before you fell 
 Pregnant? 
Professional    
Domestic    
Shop Assistant    
Hawker     
Other ………………………………….. 
All the questions we are going to ask you now 
are regarding to the consent form that you have 
signed when you agreed to participate in one of 
the Effective Care Research Unit - ECRU trials. 
That ECRU trial will from now on be referred to 
as the original study. 
 
5. Please tick the ECRU study that you 
participated in. 
PROMISE-PEP                   
ECHO       study    
AMTSL study    
NUFU surcey                             
 
6. Were you in pain or in any other 
discomfort during the time that the 
researcher obtained the informed 
consent from you for the original study? 
     Yes        No  
 
4. Ubusenza wuphi umsebenzi? 
 
Oqeqeshelweyo   
Owokucoca    
Umncedisi evenkileni   
Umthengisi    
Omnye…………………………………. 
Yonke imibuzo esiza kukubuza yona ngoku 
imalunga nefomu yemvume oye wayisayina 
ngexesha ubuvuma ukuthatha inxaxheba 
kwelinye iCandelo loPhando loNonophelo 
oLuluncedo – uvavanyo lwe-ECRU. Uvavanyo 
lwe-ECRU ukusukela ngoku kuza kubhekiswa 
kulo njengophando lokuqala. 
 
5. Korekisha uphando lwe-ECRU oye 
wathabatha inxaxheba kulo. 
PROMISE-PEP                 
Uphando lontswangciso ntsapho              
Uphando lokukhusela ukopha       
Uphengululo lwezondlo ezincinci  
6. Ingaba ubuqaqanjelwa okanye ubukuyo 
nayiphina imeko yokungonwabi 
ngexesha umphandi efumana imvume 
ecingisisiweyo kuwe yophando 
lokuqala? 
  Ewe  Hayi  
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7. If yes, do you think that the pain or 
discomfort influenced your decision to 
participate in the trial? 
Yes  No  
 
8.  Have you been given a copy of the 
informed consent of the original study 
that you have agreed to participate in? 
  Yes  No  
 
Participation 
 
9.  Were you given the opportunity to 
discuss the participation in the original 
study with your partner or confidant? 
  Yes  No  
 
10.  Why did you agree to participate in the 
original study? 
………………………………………………………
………………………………………………………
……………………………………………………… 
 
11.  Can you please explain the purpose of 
the original study? 
………………………………………………………
………………………………………………………
……………………………………………………… 
7. Ukuba uthi ‘ewe’, ucinga ukuba iintlungu 
okanye ukungonwabi kuye kwanefuthe 
kwisigqibo sakho sokuthatha inxaxheba 
kolu vavanyo?     
 Ewe  Hayi  
 
8.  Uye wanikwa ikopi yemvume 
ecingisisiweyo yophando lokuqala oye 
wavuma ukuthatha inxaxheba kulo? 
 Ewe  Hayi  
 
Uthatho-nxaxheba 
 
9.  Uye wanikwa ithuba lokuba uxoxe 
ngothatho-nxaxheba kuphando lokuqala 
kunye neqabane lakho okanye nomntu 
othembekileyo?    
 Ewe  Hayi  
10.  Kutheni ukuze uvume ukuthatha 
inxaxheba kuphando lokuqala? 
……………………………………………………….. 
……………………………………………………..... 
……………………………………………………….. 
 
11.  Ungakhe ucacise injongo yophando 
lokuqala? 
……………………………………………………… 
……………………………………………………… 
……………………………………………………… 
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12. If you know why, can you name the 
reason/s why you qualified to participate in the 
original study? 
……………………………………………………….. 
…………………………………………………......... 
 
13.  Can you mention your responsibilities 
(what was expected from you) during 
the original study? 
………………………………………………
………………………………………….......
........……………………………………… 
 
14.  Do you know when the whole study 
(origional) will end ? 
   Yes  No  
 
15.  If yes, when will it be completed? 
.............................................................................
............................................................................. 
  
16.  How long will you have to participate in 
the study? (1 visit or many visits) 
.............................................................................
............................................................................. 
 
 
 
12. Ukuba uyazi ukuba kutheni, ungakhe 
uxele isi/zizathu so/zokuba kutheni ukuze 
ukulungele ukuthatha inxaxheba kuphando 
lokuqala? 
………………………………………………………
……………………………………………………… 
13.  Ungakhe uxele uxanduva lwakho 
(yintoni ebilindelwe kuwe) ngexesha 
lophando lokuqala? 
……………………………………………………….. 
…………………………………...............…………. 
……………………………………………………….. 
 
14.  Uye waxelelwa ukuba luza kuthatha 
ixesha elingakanani uphando phambi 
kokuba lugqitywe?   
 Ewe  Hayi  
 
15.  Ukuba uthi ‘ewe’, luza kugqitywa nini? 
.............................................................................
............................................................................. 
 
16.  Uza kuthatha ixesha elingakanani 
ekuthabatheni inxaxheba kolu phando? 
.............................................................................
............................................................................. 
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Intervention (Randomized Control Trials only) 
17. When you were asked to participate in study 
      You were explained about two different 
       treatments. Can you remember what the 
       treatments were? 
     Yes  No  
18. If yes, can you name them? 
………………………………………………………
……………………………………………………… 
……………………………………………………… 
19.  What do you understand about      
 randomisation or random chance? 
.............................................................................
............................................................................. 
 
Risks and benefits 
20.  What are the possible benefits of the 
original study to you?  
.............................................................................
.............................................................................
............................................................................. 
 
21. Are you aware of any risks related to  
 The origional study? 
   Yes  No  
Ukuthatha inxaxheba  (KokweeMvavanyo 
zoLawulo ezingaKhethiyo kuphela)    
17. Ingaba ubusazi ngokhetho 
olwahlukeneyo lonyango okanye 
lokuthatha inxaxheba phambi kokuba 
usayine ifomu yemvume yophando 
lokuqala?    
                              Ewe                Hayi  
18. Ukuba uthi ‘ewe’, ibiloluphi ukhetho? 
………………………………………………………
………………………………………………………
……………………………………………………… 
19.  Ingaba yintoni oyiqondayo ngamathuba 
okufumana olunye lonyango? 
................................................................
................................................................ 
 
Imingcipheko noncedo 
20.  Loluphi uncedo onokulufumana 
kuphando lokuqala?  
.............................................................................
.............................................................................
............................................................................. 
 
21. Ingaba unalo ulwazi lwemingcipheko 
enxulumene nalo naluphina unyango 
okanye iinkqubo? 
  Ewe                Hayi  
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22. If yes, can you mention some? 
.............................................................................
.............................................................................
............................................................................. 
 
Rights and Obligations 
23. If you would not have agreed to take 
part in the original study, what 
alternatives did you have? 
.............................................................................
.............................................................................
............................................................................. 
 
24. If you choose to withdraw from the 
original study, will this have any 
consequences to you?   
  Yes  No  
 
25.   If yes, which consequences would it be? 
.............................................................................
............................................................................. 
 
26. Have you received any money from the 
researcher?    
  Yes  No  
 If yes, how much? R…………… 
 If yes, why did you get the money? 
……………………………………………………… 
22. Ukuba uthi ‘ewe’, ungakhe uxele olunye 
unyango okanye ezinye iinkqubo? 
............................................................................ 
............................................................................ 
............................................................................. 
Amalungelo neembophelelo 
23. Ukuba ubungavumanga ukuthatha 
inxaxheba kuphando lokuqala, yeyiphi 
enye indlela obunayo? 
.............................................................................
.............................................................................
............................................................................. 
 
24. Ukuba ukhetha ukurhoxa kuphando 
lokuqala, ingaba oku kuza kuba 
neziphumo kuwe?   
 Ewe  Hayi  
 
25.   Ukuba uthi ‘ewe’, zeziphi iziphumo eziza 
kubakho? 
............................................................................. 
............................................................................. 
 
26. Ingaba kukho imali oyifumene 
kumphandi?Ewe  Hayi  
Ukuba uthi ‘ewe’, yimalini? R…………… 
Ukuba uthi ‘ewe’, bekutheni ukuze 
ufumane imali? 
……………………………………………………… 
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27. What do you understand regarding the 
help available in the unexpected event of any 
trial related injuries that may occur to you while 
in the trial? 
.............................................................................
.............................................................................
............................................................................. 
 
28. Who will have access to the information 
the researcher has about you? 
.............................................................................
............................................................................. 
 
29. Could you please explain what is going 
to happen with the information we have 
gathered when the study is completed? 
………………………………………………………
……………………………………………………….. 
 
30. If you have additional questions original 
study, who would you contact (name not 
necessary)? 
............................................................................. 
31. Do you understand what your signature 
on the informed consent mean? 
   Yes  No  
 
 
27. Wazi ntoni mayela noncedo olukhoyo 
ngemeko enokuvela yokonzakala  
okunokwenzeka kuwe okunxulumene nolu 
vavanyo, ngexesha ukolu vavanyo? 
.............................................................................
.............................................................................
............................................................................. 
 
28. Ngubani oza kufikelela kulwazi 
olumalunga nawe umphandi analo? 
.............................................................................
............................................................................. 
 
29. Ungakhe uchaze ukuba kuza kwenzeka 
ntoni ngolwazi esiye saluqokelela xa olu 
phando luphelile? 
……………………………………………………….. 
……………………………………………………….. 
30. Ukuba uneminye imibuzo emalunga 
nophando lokuqala, ngubani oza 
kuqhagamshelana naye (igama 
aliyomfuneko)? 
............................................................................. 
31. Uyaqonda phofu ukuba utyikityo lwakho 
olukwimvume ecingisisiweyo luthetha 
ntoni? 
  Ewe  Hayi  
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32.  If yes, can you explain what you signed 
for? 
............................................................................. 
............................................................................. 
 
32.  Ukuba uthi ‘ewe’, ungakhe uchaze 
ukuba ubusayinela/ubutyikityela ntoni? 
……………………………………………………….. 
............................................................................
33. Do you believe that the information given  33. Ingaba ukholelwa ukuba ulwazi onikwe 
to you prior to the participation in the    lona phambi kokuthatha kwakho  
original study was sufficient to make an    inxaxheba kolu phando belanele ukuba  
educated decision in participating in the    ungenza isigqibo esisiso sokuthatha 
trial?                                                                                inxaxheba kolu vavanyo?   
Yes  No     Ewe  Hayi  
 
Thank you for participating!     Enkosi ngokuthatha kwakho inxaxheba! 
 
 
 
 
 
Name of investigator: …………………………………………………………… 
 
Name of original study (to be filled in by researcher): …………………………………………………………… 
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Informed consent form for women who attend the East London Complex Hospitals and 
the health clinics in the Amathola district, and who are invited to participate in the 
following research project. 
 
Name of Researcher:  Gaotswake Patience Moloi 
Name of Organization: University of Stellenbosch 
Name of Proposal:  Informed consent: communication and miscommunication in 
clinical trials 
Version and date:  July 2010 
Ethics approval number: N10/02/025 
 
This informed consent form has two parts: 
 Information sheet, where we share the information with you. 
 Certificate of consent, where you sign that you agree to participate. 
 
Part 1  Information sheet 
Introduction 
Dear Ms…………………….,My name is ………………………..  
This study is part of Patience Moloi's research that leads toward a Master's degree, 
studying at the University of Stellenbosch and is currently doing a study on informed 
consent: communication and miscommunication in clinical trial in Buffalo Municipality. 
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We would like to share some information with you and invite you to participate in this 
research study.  Before you decide to participate you can talk to anyone you feel 
comfortable with about the research, including your family if you wish to do so.  There 
may be some words in this form that you do not understand.  Please ask me to stop as 
we go though the information and I will take time to explain.  If you have any questions 
later, you can ask me or any other member in the research team. 
 
Purpose 
The purpose of our study is to evaluate the understanding of informed consent when 
participants consent to partake in a clinical trial or any research study.  We would like to 
find out if participants fully understand what an informed consent is and whether they 
understand why they agree to participate in a research study.  We are concerned that 
participants may not always understand and we hope that this study will help us to find 
out how we can improve the concept of obtaining informed consent from participants.  
 
Type of intervention 
This is a descriptive survey and we will conduct an interview with you that will last for 
about 30 minutes.  Your role for the purpose of this study is merely to answer a few 
questions regarding the consent form that you have signed for the clinical trial or survey 
that you are participating in.  
 
Participant selection, Procedure and Protocol 
The population will be all women participating in any of the Effective Care Research 
Unit (ECRU) studies.  You have been invited to participate in this informed consent 
study because you have signed an informed consent form for a clinical trial in one of the 
ECRU trials.  If you agree to participate in this study the researcher will ask you a few 
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questions and the answers will be written down on the data collect sheet, or 
alternatively if you can read and write will we ask you to complete the data form 
yourself.   
 
Unfamiliar procedures 
No unfamiliar procedures will be done other than to ask you some questions. 
 
Duration  
The interview that you will take part in will last approximately 30 minutes.  The study, on 
the other hand, will last until the end of November in 2010. 
 
Risks & Discomforts 
There are no risks involved in participating in this study. There are no anticipated 
discomforts in this study. 
 
Benefits  
There is no direct benefit for you but your participation may improve our understanding 
of how well participants understood informed consent.  There may not be any benefit to 
society at this stage of the research, but the results of this study may help us to 
determine if there are ways in which we could help research participants to understand 
informed consent better in the future. 
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Insurance 
The execution of the research will comply with the World Medical Association’s 
Recommendations guiding Physicians in Biomedical Research Involving Human 
Subjects, the Helsinki declaration and good clinical practice guidelines. 
 
Confidentiality  
It is possible that if others in the community are aware that you are participating in this 
research, they may ask you questions.  We will not be sharing the identity of those 
participating in the research with anyone.  The information that we collect from this 
survey will be kept confidential.  Information about you that will be collected during the 
research will not be identified by your name.  They questionnaires will be kept safely 
and your name will only be on the informed consent form.  There will be an identifying 
number on the questionnaire to match the informed consent with the questionnaire.  
This is only for research purposes.  No information gathered from you will be shared 
with or given to anyone other than the research team. 
 
Sharing the Results  
The knowledge that we get from doing this research will be shared with you before it is 
made widely available to the public.  We will put notices up at the clinic that the results 
are available and where you can get the results.  In addition there will be meetings in 
the community to share the results of the survey.  The results will also be published in 
academic journals so that other interested people may learn from our research. 
 
Voluntary participation and Right to Refuse or Withdraw  
Your participation in this research is entirely voluntary.  It is your choice whether to 
participate or not.  Whether you choose to participate or not, all the services you receive 
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at this clinic will continue and nothing will change.  You may change your mind later and 
stop participating even if you agreed to participate earlier. 
 
Alternatives to Participating  
You may choose not to participate in the study but it will not affect you in any way as 
this is just a survey. 
 
Ethical clearance 
This proposal has been reviewed and approved by the Stellenbosch University Health 
Research Committee, as well as permission from the Research unit in the East London 
Hospital Complex.  The purpose of these committees is to ensure that research 
participants are protected. If you wish to find about more about the IRB, contact 
Mandisa Singata, ECRU, Cecelia Makiwane Hospital, 082 420 1743.  
 
Who to Contact  
Ms Mandisa Singata:  work 043 708 2134, home 043 708 2426, cell: 082 420 1743 or  
email mandisa.singata@gmail.com, msingata@yahoo.com or Prof Dr Cheryl Nikodem 
at 
082 339 1204. 
 
You may contact them at any time if you have any questions related to this survey. 
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Before I ask you to sign this consent form, may I please ask you to explain to me in your 
own words what you have just read or what I have just explained to you.  I would like to 
ensure that you understand that you agree to participate in research. 
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PART II: Certificate of Consent  
I have been invited to participate in a study involving the understanding of informed 
consent:communication and miscommunication in clinical trials in the Buffalo 
municipality area, Amathole district, South Africa.  I understand that there are no risks 
involved and I am aware that there may be no benefit to me personally and that I will not 
be compensated.  I have been provided with the name of a researcher who can be 
contacted easily using the number and address I was given for that person. 
 
I have read the foregoing information, or it has been read to me.  I have had the 
opportunity to ask questions about it and any questions that I have asked have been 
answered to my satisfaction.  I consent voluntarily to participate as a participant in this 
survey and understand that I have the right to withdraw from the research at any time 
without in any way affecting my or my infant's future health care.  
 
Print Name of Participant__________________  
Signature of Participant ___________________  
Date ___________________________     
Day/month/year 
 
Print Name of Researcher________________________  
Signature of Researcher _________________________  
Date ___________________________    
Day/month/year 
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If illiterate complete this as well: 
A literate witness must sign (if possible, this person should be selected by the 
participant and should have no connection to the research team).  
 
I have witnessed the accurate reading of the consent form to the potential participant, 
and the individual has had the opportunity to ask questions.  I confirm that the individual 
has given consent freely.  
 
Print name of witness_____________________ AND  
 
Thumb print of participant 
 
Date ________________________  
          Day/month/year 
Signature of witness ______________________  
Date ________________________  
                   Day/month/year 
I have accurately read or witnessed the accurate reading of the consent form to the 
potential participant, and the individual has had the opportunity to ask questions. I 
confirm that the individual has given consent freely.  
 
Print Name of Researcher________________________  
Signature of Researcher _________________________  
Date ___________________________  
Day/month/year 
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An original copy of this Informed Consent Form has been provided to participant _____  
An original copy of this Informed Consent Form will be filed in a secure place in the 
research unit _____  
(Initialled by the researcher) 
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Iphepha Mvume Lomama abaze e East London Hospital Complex baza bathatha 
inxaxheba kwi zifundo zophando ezenziwa lisebe le effective care research 
unit.siyabamema ukuba bathathe inxaxheba kolu uphando lungezantsi: 
 
IGama loMphandi:   Gaotswake Patience Moloi 
IGama loMbutho:  IDyunivesithi  Yase Stellenboch 
IGama leSiphakamiso: Uphando olunqamleze amacandelo ukucacisa imiba yobume 
bendawo, eyentlalo-qoqosho nezenzo zokondla iintsana zoomama kuMasipala 
waseBuffalo, isithili se-Amathola  
Ubume nomhla:  UBume 0.0, Okuthowuba 2010 
Inombolo yophunyezo lwentsulungeko: N10/02/025 
 
 
Le fomu yemvume icacisayo inamacandelo amabini: 
 Uxwebhu lolwazi, apho sabelana ngolwazi kunye nawe. 
 Isiqinisekiso semvume, apho utyikitya ukuba uyavuma ukuthabatha inxaxheba. 
 
ICandelo 1  Uxwebhu lolwazi 
Intshayelelo 
 
Nksz Obekekileyo…………………….,  Igama lam ngu ………………………..  
Esi sifundo yinxalenye yophando lukaPatience Moloi olumkhokelela kwizifundo zakhe 
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zeeMaster's ekoNgeni.  Ufunda kwiDyunivesithi yaseStellenbosch kwaye kungokunje 
wenza uphando malunga nemvume ecingisisiweyo: Izinto eziyezaxoxwa 
nezingakhange zicaciswe kakuhle kwizifundo ezenziwa KwiziBedlela zalapha e Monti. 
 
Ndingathanda ukwabelana nawe ngoIwazi oluthile kwaye ndikumeme ukuba uthabathe 
inxaxheba kwesi sifundo sophando. Phambi kokuba ugqibe ukuthabatha inxaxheba 
ungathetha naye nabani na oziva ukhululekile kuye malunga nophando, kuquka usapho 
lwakho ukuba unqwenela ukwenza njalo. Kungakho amagama kule fomu 
ongawaqondiyo.  Nceda ndicele ukuba ndime njengoko siqhuba nolwazi kwaye ndiza 
kuthabatha ixesha ukucacisa. Ukuba unemibuzo emva kwexesha, ungayibuza kum 
okanye elinye ilungu elikwiqela lophando. 
 
INjongo 
Injongo zoluphando kukuhlola ukuqonda kwakho malunga nemvume ecingisisiweyo 
ngexesha ubuthatha inxaxheba kwisifundo nakunye naluphi na uphando.Sinoloyiko 
lokuba abathathi nxaxheba bangenzeka ukuba ngamanye amxesha abakuqondanga 
ncam obekucacisiwe sinethemba oluphando  
 
Uhlobo longenelelo 
Olu luphando kwaye siza kuqhuba udliwanondlebe kunye nawe oluza kuthabatha 
imizuzu engama- 30.  Ukuba uyavuma ukuthabatha inxaxheba kwesi sifundo indima 
yakho iza kukuphendula imibuzo kwiphepha lemibuzo malunga nesivumelwano 
esicingisisiweyo obusinikile kuphando obuthathe inxaxheba kulo. 
 
Uchongo lwabathabathi-nxaxheba, uMgaqo noMgaqo ongenakwaphulwa 
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Inani labantu liza ngamakhosikazi  athabathe inxaxheba kwizifundo eziphandwa lisebe 
le Effective Care Research Unit(ECRU).Uye wamenywa ukuba uthathe inxaxheba 
koluphando lwemvume icingisisiweyo ngoba ubuye watyikitya iphepha mvume uvuma 
ukuthatha inxaxheba kwesinye isifundi esiqhutywa ngu(ECRU).Ukuba uyavuma 
ukuthatha inxaxheba kwesisifundo umphandi uzakukubuza imibuzo embalwa 
,impendulo zakho zizakubhalwa kwipahepha eliqokelela incukacha ,okanye ukuba 
uyakwazi ukufunda ubhale sicele uzibhalele ngokwakho . 
 
Imigaqo engaqhelekanga 
Akukho migaqo ingaqhelakanga iza kwenziwa ngaphandle kokubuza imibuzo ethile.  
 
Ixesha elisikiweyo  
Uqokelelo lolwazi luza kuba lixesha lemizuzu eyi 30.Lona oluphando luzakuqhuba kude 
kuphele inyanga ka Novemba  2009. 
 
IMingcipheko nokungaZinzi 
Akukho mingcipheko ibandakanyekayo ekuthabatheni inxaxheba kwesi sifundo. Akukho 
kungazinzi kucingelekayo kwesi sifundo. 
 
IiNzuzo  
Akukho nzuzo ithe ngqo iza kuwe kodwa intathonxaxheba yakho inganakho ukusinceda 
ukuba sifumane impendulo kumbuzo wophando njengoko kucacisiwe ngentla apha. 
Kungangabikho nzuzo ngeli nqanaba lophando, kodwa iziphumo zolu phando 
zingasinceda ukuba sifumane ukuba zikhona na iindlela ezinokunceda oomama kwixa 
elizayo baqonde kakuhle xana benikezela imvume ecingisisiweyo. 
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I-inshorensi 
Ukuqhutywa kolu phando kuza kuhambelana neZindululo zoMbutho woNyango 
weHlabathi oKhokela ooSonzululwazi kuPhando lwezoNyango lweBhayoloji oluQuka 
iZifundo zoLuntu, isibhengezo sikaHelsinki nezikhokelo ezilungileyo zezenzo zonyango 
 
IMfihlo  
Kungenzeka ukuba abanye kuluntu bazi ukuba uthabatha inxaxheba kolu phando, 
bangakubuza imibuzo. Asizi kwabelana namntu ngabo bathabatha inxaxheba kolu 
phando.  Ulwazi esiluqokelela kolu phando luza kugcinwa luyimfihlo. Ulwazi olumalunga 
nawe oluza kuqokelelwa ngexesha lophando aluzi kwaziswa ngegama lakho. 
Amaphepha emibuzo aza kugcinwa khuselekileyo kwaye negama lakho kuphela liza 
kuba kwifomu yemvume. Kuza kubakho inombolo yokwazisa kwiphepha lemibuzo 
ukunxulumana nemvume ecacisayo kunye nephepha lemibuzo. Oku kwenzelwa 
iinjongo zophando kuphela. Akukho lwazi lufunyenwe kuwe kuza kwabelwana ngalo 
okanye lunikwe omnye umntu ngaphandle kweqela lezophando. 
 
UKwabelana ngeZiphumo  
Ulwazi esilufumana ngokwenza olu phando kuza kwabelwana ngalo nawe phambi 
kokuba lwenziwe lufumaneke kuluntu. Siza kubeka izaziso ekliniki zokuba iziphumo 
ziyafumaneka kwaye nalapho unokuzifumana khona iziphumo. Ukongeza apho kuza 
kubakho iintlanganiso kuluntu ukwabelana ngeziphumo zophando. Iziphumo kwakhona 
ziza kupapashwa kwiincwadana zezifundiswa ukuze abanye abantu abanomdla 
bafunde kolu phando lwethu 
 
Intathonxaxheba yokuzitahndela neLungelo loKwala okanye ukuRhoxa  
Intathonxaxheba yakho kolu phando ngokupheleleyo yeyokuzithandela. Ungazikhethela 
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ukuba uthabatha inxaxheba okanye hayi. Ukuba ukhetha ukuthabatha inxaxheba 
okanye hayi, zonke iinkonzo ozifumanayo kule kliniki ziza kuqhuba kwaye akuzi 
kubakho tshintsho. Ungayitshintsha ingqondo yakho emva kwexesha kwaye uyeke 
ukuthabatha inxaxheba nkqu nokuba ubusele uvumile ngaphambili ukuthabatha 
inxaxheba. Kukuwe ukuba uthabathe inxaxheba okanye hayi kwaye onke amalungelo 
akho aza kuhlala ehlonitshiwe. 
 
Okunye onokukwenza endaweni yokuThabatha inxaxheba  
Ungakhetha ukungathabathi nxaxheba kolu fundo kodwa loo nto ayizi kukuchaphazela 
nangayiphi na indlela kuba olu luphando nje. 
 
Imvume yensulungeko 
Esi siphakamiso siqwalaselwe kwakhona saza saphunyezwa yiKomiti yeNtsulungeko 
yeSineythi yeDyunivesithi yaseStellenbosch, kananjalo nekomiti yeNtsulungeko yeMonti 
eliMbaxa. Injongo yezi komiti kukuqinisekisa ukuba abathabathi-nxaxheba bophando 
bayakhuseleka. Ukuba unqwenela ukufumana ngakumbi malunga ne-IRB, 
qhagamshelana noMandisa Singata, ECRU, iSibhedlele iCecelia Makiwane, 082 420 
1743).  
 
Ngubani onkuQhagamshelana naye  
UNksz  emsebenzini Ms Patience Moloi  043 708 2120, ekhaya 043 708 2441, okanye: 
i-imeyile: pmoloi5@gmail.com 
Okanye  naye nowuphina umsebenzi ongumphandi weEffective Care Research Unit ( 
Umongikazi Okanye u Gqirha) 
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Ungaqhagamshelana nabo ngalo naliphi na ixesha unemibuzo enxulumene nolu 
phando. 
 
Phambi kokuba ndikucele ukuba utyikitye le fomu yemvume, ndingakucela ukuba 
undicacisele ngamaziw akho ngothe wakufunda kutshanje okanye le nto ndigqiba 
kukucacisela yona. Ndifuna ukuqinisekisa ukuba uyaqonda ukuba uyavuma 
ukuthabatha inxaxheba kolu phando. 
 
ICANDELO II: ISiqinisekiso seMvume  
Ndimenyiwe ukuba ndithabathe inxaxheba kuphando lokuhlola ukuqonda kwakho 
malunga nemvume ecingisisiweyo ngexesha ubuthatha inxaxheba kwisifundo nakunye 
naluphi na uphando.Sinoloyiko lokuba abathathi nxaxheba bangenzeka ukuba 
ngamanye amxesha abakuqondanga ncam obekucacisiwe sinethemba oluphando  
Ndiyaqonda ukuba akukho mingcipheko ebandakanyekayo kwaye ndiyazi ukuba akuzi 
kubakho nzuzo eza kum siqu kwaye andizi kubuyekezwa ngaphandle kweendleko 
zehambo. Ndilinikiwe igama lomphandi onokuqhagamsheleka  lula ngokusebenzisa 
inombolo nedilesi endiyinikiweyo yala mntu 
 
Ndilufundile olu lwazi luqhubayo, okanye ndilufundelwe. Ndibe nalo ithuba lokubuza 
imibuzo malunga nalo kwaye nayiphi na imibuzo endiyibuzileyo iphendulwe ndaza 
ndeneliseka. Ndiyavuma ngokuzithandela ukuthabatha inxaxheba njengomthabathi-
nxaheba kolu phando kwaye ndiyaqonda ukuba ndinalo iIungelo lokurhoxa kolu phando 
ngalo naliphi na ixesha ngaphandle kokuba kuchaphazeleke inkathalelo yezempilo yam 
neyosana lwam yexa elizayo.  
 
Bhala Phantsi iGama loMathabathi-nxaxheba__________________  
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UMtyikityo woMathabathi-nxaxheba ___________________  
UMhla ___________________________   USuku/inyanga/unyaka  
 
Bhala Phantsi iGama loMphandi________________________  
UMtyikityo woMphandi _________________________  
UMhla ___________________________  USuku/inyanga/unyaka  
 
Ukuba akukwazi kufunda nokubhala gcwalisa noku kananjalo: 
Ingqina elingakwaziyo ukufunda nokubhala malityikitye (ukuba kuyakwazeka, lo mntu 
kufuneka achongwe ngumthabathi-nxaxheba kwaye akufuneki abe uyazana neqela 
lophando).  
 
Ndikubonile ukuchaneka kokufunda kwefomu yemvume esuka kumthabathi-nxaxheba 
onokubandakanyeka, kwaye nalo mntu ulifumene ithuba lokubuza imibuzo. 
Ndiyangqina ukuba  lo mntu undinike imvume ngokukhululekileyo.  
 
Bhala phantsi igama lengqina_____________________ KUNYE  
Nobhontsi oshicilelweyo womthabathi-nxaxheba 
Umhla ________________________ USuku/inyanga/unyaka  
Umtyikityo wengqina ______________________  
Umhla ________________________ USuku/inyanga/unyaka  
Ndifunde ngokuchanekileyo okanye ndibone ukuchaneka ufundo lwefomu yemvume 
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esuka kumthabathi-nxaxheba onokubandakanyeka, kwaye nalo mntu ulifumene ithuba 
lokubuza imibuzo. Ndiyangqina ukuba  lo mntu undinike imvume ngokukhululekileyo.  
 
Bhala phantsi igama loMphandi________________________  
Umtyikityo woMphandi _________________________  
Umhla ___________________________ USuku/inyanga/unyaka  
 
Ikopi eyiyo yale Fomu yeMvume inikezelwe kumthabathi-nxaxheba _____  
Ikopi eyiyo yale Fomu yeMvume ithatyathwa isiwe ukuba ifayilishwe kwindawo 
ekhuselekileyo kwiyunithi yezophando _____ (Ifakwe amgama okuqala omphandi) 
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